BR112020002322A2 - derivados de ácido glicirretinínico para o tratamento de hipercalemia - Google Patents

Info

Publication number

BR112020002322A2

BR112020002322A2 BR112020002322-1A BR112020002322A BR112020002322A2 BR 112020002322 A2 BR112020002322 A2 BR 112020002322A2 BR 112020002322 A BR112020002322 A BR 112020002322A BR 112020002322 A2 BR112020002322 A2 BR 112020002322A2

Authority

BR

Brazil

Prior art keywords

ethoxy

oxy

inden

dihydro

methyl

Prior art date

2017-08-04

Links

• Espacenet
• Global Dossier
• Discuss

• 208000002682 Hyperkalemia Diseases 0.000 title claims abstract description 33
• 238000011282 treatment Methods 0.000 title claims description 7
• MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 title description 16
• 150000001875 compounds Chemical class 0.000 claims abstract description 186
• 150000003839 salts Chemical class 0.000 claims abstract description 49
• -1 2-morpholinoethyl Chemical group 0.000 claims description 542
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 203
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 129
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 118
• 125000000217 alkyl group Chemical group 0.000 claims description 104
• 125000000623 heterocyclic group Chemical group 0.000 claims description 91
• 125000001072 heteroaryl group Chemical group 0.000 claims description 48
• 101100451536 Arabidopsis thaliana HSD2 gene Proteins 0.000 claims description 42
• 229910052736 halogen Inorganic materials 0.000 claims description 42
• 150000002367 halogens Chemical group 0.000 claims description 42
• 229910052739 hydrogen Inorganic materials 0.000 claims description 41
• 238000000034 method Methods 0.000 claims description 41
• 239000001257 hydrogen Substances 0.000 claims description 39
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 39
• 241000124008 Mammalia Species 0.000 claims description 37
• 125000003118 aryl group Chemical group 0.000 claims description 37
• 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 35
• 125000004043 oxo group Chemical group O=* 0.000 claims description 31
• 125000002947 alkylene group Chemical group 0.000 claims description 30
• JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 28
• 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 25
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 24
• 229910052799 carbon Inorganic materials 0.000 claims description 24
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 23
• 238000006243 chemical reaction Methods 0.000 claims description 20
• 229910052760 oxygen Inorganic materials 0.000 claims description 20
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 17
• 229960000890 hydrocortisone Drugs 0.000 claims description 14
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 13
• 230000000112 colonic effect Effects 0.000 claims description 13
• 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 12
• 239000003814 drug Substances 0.000 claims description 12
• 125000001188 haloalkyl group Chemical group 0.000 claims description 11
• 230000002401 inhibitory effect Effects 0.000 claims description 10
• 230000028327 secretion Effects 0.000 claims description 10
• 229940079593 drug Drugs 0.000 claims description 9
• 125000004423 acyloxy group Chemical group 0.000 claims description 8
• FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 claims description 7
• MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 claims description 7
• MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 claims description 7
• 229960004544 cortisone Drugs 0.000 claims description 7
• 239000008194 pharmaceutical composition Substances 0.000 claims description 7
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
• 229910001414 potassium ion Inorganic materials 0.000 claims description 7
• 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims description 6
• 150000001412 amines Chemical group 0.000 claims description 6
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
• 239000003085 diluting agent Substances 0.000 claims description 5
• 230000001737 promoting effect Effects 0.000 claims description 5
• 208000035475 disorder Diseases 0.000 claims description 4
• 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims description 3
• GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 3
• NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 3
• 238000004519 manufacturing process Methods 0.000 claims description 3
• 239000003937 drug carrier Substances 0.000 claims description 2
• CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims description 2
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
• 150000003852 triazoles Chemical class 0.000 claims description 2
• 201000010099 disease Diseases 0.000 claims 2
• 230000001404 mediated effect Effects 0.000 claims 2
• OQQTZLSEKBDXRS-UHFFFAOYSA-N propan-2-yl propan-2-yloxycarbonyl carbonate Chemical compound CC(C)OC(=O)OC(=O)OC(C)C OQQTZLSEKBDXRS-UHFFFAOYSA-N 0.000 claims 1
• 239000003112 inhibitor Substances 0.000 abstract description 51
• 102000004277 11-beta-hydroxysteroid dehydrogenases Human genes 0.000 abstract description 3
• 108090000874 11-beta-hydroxysteroid dehydrogenases Proteins 0.000 abstract description 3
• 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 351
• 239000002253 acid Substances 0.000 description 197
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 190
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 183
• 239000000243 solution Substances 0.000 description 183
• 239000007787 solid Substances 0.000 description 180
• 239000000203 mixture Substances 0.000 description 177
• 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 description 177
• 229910052757 nitrogen Inorganic materials 0.000 description 174
• 238000003786 synthesis reaction Methods 0.000 description 137
• 230000015572 biosynthetic process Effects 0.000 description 129
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 102
• 239000004202 carbamide Substances 0.000 description 95
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 90
• 229910001868 water Inorganic materials 0.000 description 88
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 84
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 81
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 69
• 102100022897 Sodium/hydrogen exchanger 10 Human genes 0.000 description 67
• 238000001914 filtration Methods 0.000 description 64
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 63
• 239000011591 potassium Substances 0.000 description 63
• 229910052700 potassium Inorganic materials 0.000 description 62
• KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 59
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 58
• KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 55
• 238000005160 1H NMR spectroscopy Methods 0.000 description 54
• 239000012043 crude product Substances 0.000 description 54
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 53
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 51
• 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 48
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 48
• 230000027455 binding Effects 0.000 description 47
• DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 47
• 239000000741 silica gel Substances 0.000 description 44
• 229910002027 silica gel Inorganic materials 0.000 description 44
• OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 43
• 235000019439 ethyl acetate Nutrition 0.000 description 42
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 37
• 238000002953 preparative HPLC Methods 0.000 description 35
• 101000610640 Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp3 Proteins 0.000 description 33
• 101001110823 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-A Proteins 0.000 description 33
• 101000712176 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-B Proteins 0.000 description 33
• 102100040374 U4/U6 small nuclear ribonucleoprotein Prp3 Human genes 0.000 description 33
• 239000012298 atmosphere Substances 0.000 description 33
• 239000003208 petroleum Substances 0.000 description 32
• 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 31
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 31
• 102000003979 Mineralocorticoid Receptors Human genes 0.000 description 28
• 108090000375 Mineralocorticoid Receptors Proteins 0.000 description 28
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 28
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 25
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 24
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 22
• PEDPVHYNSCOTLR-UAOJZALGSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=CC=CC=C1 PEDPVHYNSCOTLR-UAOJZALGSA-N 0.000 description 20
• 239000012267 brine Substances 0.000 description 20
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 20
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 19
• 238000004128 high performance liquid chromatography Methods 0.000 description 19
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 19
• 239000012044 organic layer Substances 0.000 description 19
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 18
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 18
• 125000005842 heteroatom Chemical group 0.000 description 18
• 238000003756 stirring Methods 0.000 description 18
• JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-dimethylaminophenol Chemical compound CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 description 17
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 17
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 17
• 239000000047 product Substances 0.000 description 17
• 108091006649 SLC9A3 Proteins 0.000 description 15
• 239000000556 agonist Substances 0.000 description 15
• 210000004940 nucleus Anatomy 0.000 description 15
• 125000006239 protecting group Chemical group 0.000 description 15
• 229910052717 sulfur Inorganic materials 0.000 description 15
• 102100030375 Sodium/hydrogen exchanger 3 Human genes 0.000 description 14
• DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 14
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 14
• ACNQSEAJFQHYLI-LEYZWCBYSA-N (2S,4aS,6aR,6aS,6bR,8aS,10S,12aS,14bR)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2,10-dicarboxylic acid Chemical compound CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)C(O)=O ACNQSEAJFQHYLI-LEYZWCBYSA-N 0.000 description 13
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 13
• 125000001424 substituent group Chemical group 0.000 description 13
• 125000003545 alkoxy group Chemical group 0.000 description 12
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 12
• 230000029142 excretion Effects 0.000 description 12
• 239000011734 sodium Substances 0.000 description 12
• 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 11
• 239000003795 chemical substances by application Substances 0.000 description 11
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 11
• 239000003921 oil Substances 0.000 description 11
• 229910000027 potassium carbonate Inorganic materials 0.000 description 11
• 150000003384 small molecules Chemical class 0.000 description 11
• YSERCIHBCXZJHY-HKUYNNGSSA-N (1S,2S)-6-chloro-2-(dimethylamino)-1-(2-methylphenoxy)-2,3-dihydro-1H-indene-4-carbonitrile Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)C)N(C)C)C#N YSERCIHBCXZJHY-HKUYNNGSSA-N 0.000 description 10
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 10
• MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 10
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 10
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 10
• 239000011230 binding agent Substances 0.000 description 10
• 230000000694 effects Effects 0.000 description 10
• 229960003720 enoxolone Drugs 0.000 description 10
• 238000009472 formulation Methods 0.000 description 10
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 9
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 9
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
• 125000004429 atom Chemical group 0.000 description 9
• 210000004027 cell Anatomy 0.000 description 9
• 208000020832 chronic kidney disease Diseases 0.000 description 9
• 239000000651 prodrug Substances 0.000 description 9
• 229940002612 prodrug Drugs 0.000 description 9
• 229920006395 saturated elastomer Polymers 0.000 description 9
• 210000002966 serum Anatomy 0.000 description 9
• 125000003107 substituted aryl group Chemical group 0.000 description 9
• WNWOGOMGWXFMIZ-WMZOPIPTSA-N (1S,2S)-4,6-dichloro-N,N-dimethyl-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=C(C=CC=C1)C)N(C)C WNWOGOMGWXFMIZ-WMZOPIPTSA-N 0.000 description 8
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 8
• 125000004122 cyclic group Chemical group 0.000 description 8
• 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 8
• 239000000543 intermediate Substances 0.000 description 8
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 8
• 229910052698 phosphorus Inorganic materials 0.000 description 8
• 239000011347 resin Substances 0.000 description 8
• 229920005989 resin Polymers 0.000 description 8
• DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 8
• 210000001519 tissue Anatomy 0.000 description 8
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 7
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
• 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 7
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
• 235000012538 ammonium bicarbonate Nutrition 0.000 description 7
• 239000000460 chlorine Substances 0.000 description 7
• 229910052801 chlorine Inorganic materials 0.000 description 7
• 210000001072 colon Anatomy 0.000 description 7
• RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 7
• 230000003834 intracellular effect Effects 0.000 description 7
• 229910000069 nitrogen hydride Inorganic materials 0.000 description 7
• 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 7
• 235000015320 potassium carbonate Nutrition 0.000 description 7
• 229940083542 sodium Drugs 0.000 description 7
• 125000000547 substituted alkyl group Chemical group 0.000 description 7
• 229940124530 sulfonamide Drugs 0.000 description 7
• 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 6
• 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 6
• 125000006701 (C1-C7) alkyl group Chemical group 0.000 description 6
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 6
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
• 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 6
• 239000007821 HATU Substances 0.000 description 6
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
• 229920002472 Starch Polymers 0.000 description 6
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 6
• 230000004913 activation Effects 0.000 description 6
• 125000002252 acyl group Chemical group 0.000 description 6
• 125000004432 carbon atom Chemical group C* 0.000 description 6
• MYRTYDVEIRVNKP-UHFFFAOYSA-N divinylbenzene Substances C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 6
• 230000005764 inhibitory process Effects 0.000 description 6
• 210000003734 kidney Anatomy 0.000 description 6
• 239000008141 laxative Substances 0.000 description 6
• 230000002475 laxative effect Effects 0.000 description 6
• 239000003446 ligand Substances 0.000 description 6
• 230000007246 mechanism Effects 0.000 description 6
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 6
• 229920001515 polyalkylene glycol Polymers 0.000 description 6
• 229920001223 polyethylene glycol Polymers 0.000 description 6
• 229910052708 sodium Inorganic materials 0.000 description 6
• 239000008107 starch Substances 0.000 description 6
• 235000019698 starch Nutrition 0.000 description 6
• 239000007858 starting material Substances 0.000 description 6
• 150000003456 sulfonamides Chemical class 0.000 description 6
• ICOFTVTWIRQJFG-UHFFFAOYSA-N 1,2,3,4,4a,5,6,6a,6a,6b,7,8,8a,9,10,11,12,12a,13,14b-icosahydropicene-2-carboxylic acid Chemical compound C1C(CCC2CCC3C4CCC5CCCCC5C4CC=C3C21)C(=O)O ICOFTVTWIRQJFG-UHFFFAOYSA-N 0.000 description 5
• LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 5
• FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 5
• QETVYTNAHZLDNS-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)benzenesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(N)(=O)=O)C=C1 QETVYTNAHZLDNS-UHFFFAOYSA-N 0.000 description 5
• 239000005541 ACE inhibitor Substances 0.000 description 5
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 5
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
• 239000002202 Polyethylene glycol Substances 0.000 description 5
• RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 5
• 239000007983 Tris buffer Substances 0.000 description 5
• 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 5
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
• 238000004587 chromatography analysis Methods 0.000 description 5
• 125000000753 cycloalkyl group Chemical group 0.000 description 5
• 238000003818 flash chromatography Methods 0.000 description 5
• IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
• 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
• 125000005647 linker group Chemical group 0.000 description 5
• 210000002220 organoid Anatomy 0.000 description 5
• 229920001467 poly(styrenesulfonates) Polymers 0.000 description 5
• 229920000642 polymer Polymers 0.000 description 5
• 230000036454 renin-angiotensin system Effects 0.000 description 5
• 239000012453 solvate Substances 0.000 description 5
• 239000011593 sulfur Substances 0.000 description 5
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
• ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 5
• VFWPQDLLPSTMCF-JJXUHFIVSA-N (3R)-1-[(1S,2S)-6-chloro-1-(2-fluorophenoxy)-4-methyl-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)C)Cl)OC1=C(C=CC=C1)F VFWPQDLLPSTMCF-JJXUHFIVSA-N 0.000 description 4
• 125000003161 (C1-C6) alkylene group Chemical group 0.000 description 4
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
• YIKSCQDJHCMVMK-UHFFFAOYSA-N Oxamide Chemical compound NC(=O)C(N)=O YIKSCQDJHCMVMK-UHFFFAOYSA-N 0.000 description 4
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
• 241001582429 Tetracis Species 0.000 description 4
• VYWQTJWGWLKBQA-UHFFFAOYSA-N [amino(hydroxy)methylidene]azanium;chloride Chemical compound Cl.NC(N)=O VYWQTJWGWLKBQA-UHFFFAOYSA-N 0.000 description 4
• 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 4
• 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 4
• 239000002333 angiotensin II receptor antagonist Substances 0.000 description 4
• 229940125364 angiotensin receptor blocker Drugs 0.000 description 4
• 125000004657 aryl sulfonyl amino group Chemical group 0.000 description 4
• RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
• 229910052681 coesite Inorganic materials 0.000 description 4
• 229910052906 cristobalite Inorganic materials 0.000 description 4
• 210000003608 fece Anatomy 0.000 description 4
• 230000006870 function Effects 0.000 description 4
• 210000001035 gastrointestinal tract Anatomy 0.000 description 4
• 229960004949 glycyrrhizic acid Drugs 0.000 description 4
• 235000019410 glycyrrhizin Nutrition 0.000 description 4
• LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
• 230000000968 intestinal effect Effects 0.000 description 4
• 239000006166 lysate Substances 0.000 description 4
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
• 210000004379 membrane Anatomy 0.000 description 4
• 239000012528 membrane Substances 0.000 description 4
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
• 239000001301 oxygen Substances 0.000 description 4
• 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 4
• 125000003386 piperidinyl group Chemical group 0.000 description 4
• 235000011181 potassium carbonates Nutrition 0.000 description 4
• 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 4
• 125000002098 pyridazinyl group Chemical group 0.000 description 4
• 125000000719 pyrrolidinyl group Chemical group 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 239000000377 silicon dioxide Substances 0.000 description 4
• 235000012239 silicon dioxide Nutrition 0.000 description 4
• 235000017557 sodium bicarbonate Nutrition 0.000 description 4
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
• 229910052682 stishovite Inorganic materials 0.000 description 4
• 229910052905 tridymite Inorganic materials 0.000 description 4
• CNYWFSZRTXVYQL-COCIYFACSA-N (2S,4aS,6aR,6aS,6bR,8aR,12aS,14bR)-10-methoxycarbonyl-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,12,14b-decahydro-1H-picene-2-carboxylic acid Chemical compound COC(=O)C1=CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2C(=O)C=C2[C@@H]4C[C@](C)(CC[C@]4(C)CC[C@@]32C)C(O)=O)C1(C)C CNYWFSZRTXVYQL-COCIYFACSA-N 0.000 description 3
• VYYMSFMSMYDCOM-JJXUHFIVSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=C(C=CC=C1)C VYYMSFMSMYDCOM-JJXUHFIVSA-N 0.000 description 3
• 125000001506 1,2,3-triazol-5-yl group Chemical group [H]N1N=NC([H])=C1[*] 0.000 description 3
• OPNPICUNZBLILY-UHFFFAOYSA-N 2-[2-(2-methoxyethoxy)ethoxy]ethyl propanoate Chemical compound CCC(=O)OCCOCCOCCOC OPNPICUNZBLILY-UHFFFAOYSA-N 0.000 description 3
• WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
• NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 3
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
• 206010019280 Heart failures Diseases 0.000 description 3
• 206010020772 Hypertension Diseases 0.000 description 3
• WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
• 239000007832 Na2SO4 Substances 0.000 description 3
• 108020005497 Nuclear hormone receptor Proteins 0.000 description 3
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
• 229960002478 aldosterone Drugs 0.000 description 3
• 125000001931 aliphatic group Chemical group 0.000 description 3
• 125000000304 alkynyl group Chemical group 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 3
• 125000001821 azanediyl group Chemical group [H]N(*)* 0.000 description 3
• 125000002619 bicyclic group Chemical group 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 239000011575 calcium Substances 0.000 description 3
• 159000000007 calcium salts Chemical class 0.000 description 3
• 239000002775 capsule Substances 0.000 description 3
• 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 230000001684 chronic effect Effects 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 125000000392 cycloalkenyl group Chemical group 0.000 description 3
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 3
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 3
• UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
• LZBWNAIUNVRCSU-UHFFFAOYSA-N dimethyl 2-(1,3-dimethoxy-1,3-dioxopropan-2-yl)oxypropanedioate Chemical compound COC(=O)C(C(=O)OC)OC(C(=O)OC)C(=O)OC LZBWNAIUNVRCSU-UHFFFAOYSA-N 0.000 description 3
• 239000002552 dosage form Substances 0.000 description 3
• 150000002148 esters Chemical class 0.000 description 3
• 239000000284 extract Substances 0.000 description 3
• 125000000524 functional group Chemical group 0.000 description 3
• LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
• UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
• 125000001183 hydrocarbyl group Chemical group 0.000 description 3
• 210000000936 intestine Anatomy 0.000 description 3
• JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 3
• GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium;hydroxide;hydrate Chemical compound [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 3
• 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 3
• 125000004433 nitrogen atom Chemical group N* 0.000 description 3
• 231100000252 nontoxic Toxicity 0.000 description 3
• 230000003000 nontoxic effect Effects 0.000 description 3
• 102000006255 nuclear receptors Human genes 0.000 description 3
• 108020004017 nuclear receptors Proteins 0.000 description 3
• 229910052763 palladium Inorganic materials 0.000 description 3
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
• 238000002360 preparation method Methods 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 125000004942 pyridazin-6-yl group Chemical group N1=NC=CC=C1* 0.000 description 3
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
• 125000004076 pyridyl group Chemical group 0.000 description 3
• 210000000813 small intestine Anatomy 0.000 description 3
• 229910001415 sodium ion Inorganic materials 0.000 description 3
• 229910052938 sodium sulfate Inorganic materials 0.000 description 3
• 235000011152 sodium sulphate Nutrition 0.000 description 3
• 239000002904 solvent Chemical group 0.000 description 3
• KYVINBMBHZGKHZ-AGHHOFFYSA-N (1S,2S)-2-[(3R)-3-aminopiperidin-1-yl]-6-chloro-1-(2-methylphenoxy)-2,3-dihydro-1H-indene-4-carbonitrile Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)C#N)Cl)OC1=C(C=CC=C1)C KYVINBMBHZGKHZ-AGHHOFFYSA-N 0.000 description 2
• OWQVZHGTFBYENZ-HKUYNNGSSA-N (1S,2S)-4,6-dichloro-1-(2,5-dimethylphenoxy)-N,N-dimethyl-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=CC(=CC=C1C)C)N(C)C OWQVZHGTFBYENZ-HKUYNNGSSA-N 0.000 description 2
• ZGOFCJCZWCXORQ-WMZOPIPTSA-N (1S,2S)-4,6-dichloro-1-(2-fluoro-5-methylphenoxy)-N,N-dimethyl-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=CC(=CC=C1F)C)N(C)C ZGOFCJCZWCXORQ-WMZOPIPTSA-N 0.000 description 2
• KMIDHFBRKQKTJI-WMZOPIPTSA-N (1S,2S)-4,6-dichloro-1-(2-fluoro-6-methylphenoxy)-N,N-dimethyl-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=C(C=CC=C1C)F)N(C)C KMIDHFBRKQKTJI-WMZOPIPTSA-N 0.000 description 2
• XTPRMKUBBUPKPG-RDJZCZTQSA-N (1S,2S)-4,6-dichloro-1-(2-fluorophenoxy)-N,N-dimethyl-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=C(C=CC=C1)F)N(C)C XTPRMKUBBUPKPG-RDJZCZTQSA-N 0.000 description 2
• DCKPOUWIHLAWQF-WMZOPIPTSA-N (1S,2S)-4,6-dichloro-1-(5-fluoro-2-methylphenoxy)-N,N-dimethyl-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=CC(=CC=C1C)F)N(C)C DCKPOUWIHLAWQF-WMZOPIPTSA-N 0.000 description 2
• ZOQHYQUCMYPPPH-ICSRJNTNSA-N (1S,2S)-6-chloro-1-(2-fluorophenoxy)-2-piperazin-1-yl-2,3-dihydro-1H-indene-4-carbonitrile Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)F)N1CCNCC1)C#N ZOQHYQUCMYPPPH-ICSRJNTNSA-N 0.000 description 2
• KQOWKWWQVJXBIU-WMZOPIPTSA-N (1S,2S)-6-chloro-1-(2-fluorophenoxy)-N,N,4-trimethyl-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)F)N(C)C)C KQOWKWWQVJXBIU-WMZOPIPTSA-N 0.000 description 2
• DMCUTRXBEQFUEQ-FPOVZHCZSA-N (1S,2S)-6-chloro-1-(2-methylphenoxy)-2-piperazin-1-yl-2,3-dihydro-1H-indene-4-carbonitrile Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)C)N1CCNCC1)C#N DMCUTRXBEQFUEQ-FPOVZHCZSA-N 0.000 description 2
• NHJVOVQTOWFPKK-WMZOPIPTSA-N (1S,2S)-6-chloro-2-(dimethylamino)-1-(2-fluorophenoxy)-2,3-dihydro-1H-indene-4-carbonitrile Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)F)N(C)C)C#N NHJVOVQTOWFPKK-WMZOPIPTSA-N 0.000 description 2
• PYDZWZVHWHDFQY-ROUUACIJSA-N (1S,2S)-6-chloro-2-(dimethylamino)-1-phenoxy-2,3-dihydro-1H-indene-4-carbonitrile Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=CC=CC=C1)N(C)C)C#N PYDZWZVHWHDFQY-ROUUACIJSA-N 0.000 description 2
• YMJLTRPVOPDHAO-FHZYATBESA-N (1S,2S)-6-chloro-2-[(3R)-3-(dimethylamino)piperidin-1-yl]-1-(2-fluorophenoxy)-2,3-dihydro-1H-indene-4-carbonitrile Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)F)N1C[C@@H](CCC1)N(C)C)C#N YMJLTRPVOPDHAO-FHZYATBESA-N 0.000 description 2
• FPPZSNFQJKHGCS-UCFCWBNQSA-N (1S,2S)-6-chloro-2-[(3R)-3-(dimethylamino)piperidin-1-yl]-1-(2-methylphenoxy)-2,3-dihydro-1H-indene-4-carbonitrile Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)C)N1C[C@@H](CCC1)N(C)C)C#N FPPZSNFQJKHGCS-UCFCWBNQSA-N 0.000 description 2
• YLVBAFKBNUDSAN-WMZOPIPTSA-N (1S,2S)-6-chloro-4-fluoro-N,N-dimethyl-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)C)N(C)C)F YLVBAFKBNUDSAN-WMZOPIPTSA-N 0.000 description 2
• VAOLAFDIEIGNBG-LPHOPBHVSA-N (1S,2S)-6-chloro-4-methoxy-N,N-dimethyl-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)C)N(C)C)OC VAOLAFDIEIGNBG-LPHOPBHVSA-N 0.000 description 2
• RQTRGXSLUODENZ-HKUYNNGSSA-N (1S,2S)-6-chloro-N,N,4-trimethyl-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)C)N(C)C)C RQTRGXSLUODENZ-HKUYNNGSSA-N 0.000 description 2
• AHOPHDAIWIOWRV-YJBOKZPZSA-N (1S,2S)-6-chloro-N,N-dimethyl-1-(2-methylphenoxy)-4-(trifluoromethoxy)-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)C)N(C)C)OC(F)(F)F AHOPHDAIWIOWRV-YJBOKZPZSA-N 0.000 description 2
• DBBLGICFXRGLPB-WMZOPIPTSA-N (1S,2S)-6-chloro-N,N-dimethyl-1-(2-methylphenoxy)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)C)N(C)C)C(F)(F)F DBBLGICFXRGLPB-WMZOPIPTSA-N 0.000 description 2
• AYIJVRFAKSGFNR-RDJZCZTQSA-N (1S,2S)-6-chloro-N,N-dimethyl-1-phenoxy-4-(trifluoromethoxy)-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=CC=CC=C1)N(C)C)OC(F)(F)F AYIJVRFAKSGFNR-RDJZCZTQSA-N 0.000 description 2
• WDYMGDZLHYUOTM-IRXDYDNUSA-N (1S,2S)-6-chloro-N,N-dimethyl-1-phenoxy-4-(trifluoromethyl)-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=CC=CC=C1)N(C)C)C(F)(F)F WDYMGDZLHYUOTM-IRXDYDNUSA-N 0.000 description 2
• MEDBWSYQNRHALF-OREJSRFESA-N (2R)-1-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]-2-methylpiperidine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=CC=CC=C1)N1[C@@H](CCCC1)C MEDBWSYQNRHALF-OREJSRFESA-N 0.000 description 2
• MEDBWSYQNRHALF-WVFSVQOHSA-N (2S)-1-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]-2-methylpiperidine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=CC=CC=C1)N1[C@H](CCCC1)C MEDBWSYQNRHALF-WVFSVQOHSA-N 0.000 description 2
• VGTHQGYGDALBKQ-BUVFEPMLSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(2,5-dimethylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=CC(=CC=C1C)C VGTHQGYGDALBKQ-BUVFEPMLSA-N 0.000 description 2
• MGUAZMMAMOSAPL-BUVFEPMLSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(2,6-dimethylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=C(C=CC=C1C)C MGUAZMMAMOSAPL-BUVFEPMLSA-N 0.000 description 2
• BSHPELRGWWZVIK-RFVSGWPVSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(2-fluoro-5-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=CC(=CC=C1F)C BSHPELRGWWZVIK-RFVSGWPVSA-N 0.000 description 2
• ZBPKKTZQHQNRHT-RFVSGWPVSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(2-fluoro-6-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=C(C=CC=C1C)F ZBPKKTZQHQNRHT-RFVSGWPVSA-N 0.000 description 2
• DRDSSMUUBUPJOR-PDXHDDNESA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(2-fluorophenoxy)-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpiperidin-3-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=C(C=CC=C1)F)N1C[C@@H](CCC1)N(C)C DRDSSMUUBUPJOR-PDXHDDNESA-N 0.000 description 2
• TZBYXQMGPKORFS-FHZYATBESA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpiperidin-3-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=C(C=CC=C1)C)N1C[C@@H](CCC1)N(C)C TZBYXQMGPKORFS-FHZYATBESA-N 0.000 description 2
• MSTLXKIZWUDOOH-JJXUHFIVSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(5-fluoro-2-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=CC(=CC=C1C)F MSTLXKIZWUDOOH-JJXUHFIVSA-N 0.000 description 2
• UIDCLGXCVNWEGX-DKLXNKCPSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]-N-methyl-N-propan-2-ylpiperidin-3-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=CC=CC=C1)N1C[C@@H](CCC1)N(C(C)C)C UIDCLGXCVNWEGX-DKLXNKCPSA-N 0.000 description 2
• GXDNTTPGGWXXIL-FHZYATBESA-N (3R)-1-[(1S,2S)-6-chloro-1-(2-fluorophenoxy)-4-methyl-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpiperidin-3-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)F)N1C[C@@H](CCC1)N(C)C)C GXDNTTPGGWXXIL-FHZYATBESA-N 0.000 description 2
• SEORSPRXTZOAEW-JJXUHFIVSA-N (3R)-1-[(1S,2S)-6-chloro-4-fluoro-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)F)Cl)OC1=C(C=CC=C1)C SEORSPRXTZOAEW-JJXUHFIVSA-N 0.000 description 2
• YDJNOHQXAKCURE-WVBUVRCRSA-N (3R)-1-[(1S,2S)-6-chloro-4-methoxy-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)OC)Cl)OC1=C(C=CC=C1)C YDJNOHQXAKCURE-WVBUVRCRSA-N 0.000 description 2
• KFDAHSYXDAQRAX-JJXUHFIVSA-N (3R)-1-[(1S,2S)-6-chloro-4-methoxy-1-phenoxy-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)OC)Cl)OC1=CC=CC=C1 KFDAHSYXDAQRAX-JJXUHFIVSA-N 0.000 description 2
• JJOLDSNPRHXANB-AGHHOFFYSA-N (3R)-1-[(1S,2S)-6-chloro-4-methyl-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)C)Cl)OC1=C(C=CC=C1)C JJOLDSNPRHXANB-AGHHOFFYSA-N 0.000 description 2
• IENDCMGNBPYSHJ-LEOXJPRUSA-N (3R)-1-[(1S,2S)-6-chloro-4-methyl-1-phenoxy-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpiperidin-3-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=CC=CC=C1)N1C[C@@H](CCC1)N(C)C)C IENDCMGNBPYSHJ-LEOXJPRUSA-N 0.000 description 2
• KTDFTGSLEJNRMB-CZAAIQMYSA-N (3R)-1-[(1S,2S)-6-chloro-4-methyl-1-phenoxy-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)C)Cl)OC1=CC=CC=C1 KTDFTGSLEJNRMB-CZAAIQMYSA-N 0.000 description 2
• 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 2
• 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 2
• 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 description 2
• 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 2
• 125000004505 1,2,4-oxadiazol-5-yl group Chemical group O1N=CN=C1* 0.000 description 2
• 125000004516 1,2,4-thiadiazol-5-yl group Chemical group S1N=CN=C1* 0.000 description 2
• 125000004510 1,3,4-oxadiazol-5-yl group Chemical group O1C=NN=C1* 0.000 description 2
• QZDBZWJIQUUFBJ-UHFFFAOYSA-N 1,3-bis[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]urea Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCNC(=O)NCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 QZDBZWJIQUUFBJ-UHFFFAOYSA-N 0.000 description 2
• DHMMDFMPRFIJJG-HKUYNNGSSA-N 1-[(1S,2S)-4,6-dichloro-1-(2-fluorophenoxy)-2,3-dihydro-1H-inden-2-yl]piperazine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=C(C=CC=C1)F)N1CCNCC1 DHMMDFMPRFIJJG-HKUYNNGSSA-N 0.000 description 2
• UASUYVALMWHGLK-FPOVZHCZSA-N 1-[(1S,2S)-4,6-dichloro-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]-4-methylpiperazine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=C(C=CC=C1)C)N1CCN(CC1)C UASUYVALMWHGLK-FPOVZHCZSA-N 0.000 description 2
• CPDDKZCZDLPGTC-ICSRJNTNSA-N 1-[(1S,2S)-4,6-dichloro-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperazine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=C(C=CC=C1)C)N1CCNCC1 CPDDKZCZDLPGTC-ICSRJNTNSA-N 0.000 description 2
• BAEOTOGOYAGOLU-OALUTQOASA-N 1-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]piperazine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=CC=CC=C1)N1CCNCC1 BAEOTOGOYAGOLU-OALUTQOASA-N 0.000 description 2
• OWVYKGJIPYGWNL-ICSRJNTNSA-N 1-[(1S,2S)-6-chloro-1-(2-fluorophenoxy)-4-methyl-2,3-dihydro-1H-inden-2-yl]piperazine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)F)N1CCNCC1)C OWVYKGJIPYGWNL-ICSRJNTNSA-N 0.000 description 2
• BFWLNRVEEPBRQL-FPOVZHCZSA-N 1-[(1S,2S)-6-chloro-4-methyl-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperazine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)C)N1CCNCC1)C BFWLNRVEEPBRQL-FPOVZHCZSA-N 0.000 description 2
• KKFDCBRMNNSAAW-UHFFFAOYSA-N 2-(morpholin-4-yl)ethanol Chemical compound OCCN1CCOCC1 KKFDCBRMNNSAAW-UHFFFAOYSA-N 0.000 description 2
• WKWSKSNCYLOVOO-NMCSBDFUSA-N 2-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]-2-azabicyclo[2.2.1]heptane Chemical compound C12N(CC(CC1)C2)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=CC=CC=C1 WKWSKSNCYLOVOO-NMCSBDFUSA-N 0.000 description 2
• 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 2
• 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 2
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
• LPXPSNRNOUXNEX-UHFFFAOYSA-N 3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-[[4-[[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]methyl]phenyl]methyl]benzenesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCC=2C=CC(CNS(=O)(=O)C=3C=C(C=CC=3)C3C4=CC(Cl)=CC(Cl)=C4CN(C)C3)=CC=2)=C1 LPXPSNRNOUXNEX-UHFFFAOYSA-N 0.000 description 2
• IYJCXZLEPPYWNL-WZRIXLNXSA-N 8-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]-8-azabicyclo[3.2.1]octane Chemical compound C12CCCC(CC1)N2[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=CC=CC=C1 IYJCXZLEPPYWNL-WZRIXLNXSA-N 0.000 description 2
• 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 2
• 101100243950 Arabidopsis thaliana PIE1 gene Proteins 0.000 description 2
• 101100515516 Arabidopsis thaliana XI-H gene Proteins 0.000 description 2
• 108010043769 CLC-2 Chloride Channels Proteins 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• 229920000623 Cellulose acetate phthalate Polymers 0.000 description 2
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
• XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 2
• ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
• QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
• 241000202807 Glycyrrhiza Species 0.000 description 2
• 239000004378 Glycyrrhizin Substances 0.000 description 2
• 108010078321 Guanylate Cyclase Proteins 0.000 description 2
• 102000014469 Guanylate cyclase Human genes 0.000 description 2
• 208000019025 Hypokalemia Diseases 0.000 description 2
• 102000004877 Insulin Human genes 0.000 description 2
• 108090001061 Insulin Proteins 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
• RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 2
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
• IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
• CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
• RPLHIDLAYRDZBE-CZAAIQMYSA-N N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)C#N)Cl)OC1=CC=CC=C1 Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)C#N)Cl)OC1=CC=CC=C1 RPLHIDLAYRDZBE-CZAAIQMYSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
• 239000000370 acceptor Substances 0.000 description 2
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 125000004656 alkyl sulfonylamino group Chemical group 0.000 description 2
• MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 description 2
• 229910021529 ammonia Inorganic materials 0.000 description 2
• RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
• 230000001162 anti-hypercalcemic effect Effects 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 125000003710 aryl alkyl group Chemical group 0.000 description 2
• 235000010323 ascorbic acid Nutrition 0.000 description 2
• 239000011668 ascorbic acid Substances 0.000 description 2
• 238000003556 assay Methods 0.000 description 2
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
• JHVLLYQQQYIWKX-UHFFFAOYSA-N benzyl 2-bromoacetate Chemical compound BrCC(=O)OCC1=CC=CC=C1 JHVLLYQQQYIWKX-UHFFFAOYSA-N 0.000 description 2
• WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
• 229960001948 caffeine Drugs 0.000 description 2
• VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 2
• 125000004452 carbocyclyl group Chemical group 0.000 description 2
• 125000002843 carboxylic acid group Chemical group 0.000 description 2
• 125000006244 carboxylic acid protecting group Chemical group 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229940081734 cellulose acetate phthalate Drugs 0.000 description 2
• 239000003467 chloride channel stimulating agent Substances 0.000 description 2
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
• 229960001231 choline Drugs 0.000 description 2
• 229920001577 copolymer Polymers 0.000 description 2
• 238000002425 crystallisation Methods 0.000 description 2
• 125000004093 cyano group Chemical group *C#N 0.000 description 2
• 206010012601 diabetes mellitus Diseases 0.000 description 2
• 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 2
• SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
• ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
• ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 239000002934 diuretic Substances 0.000 description 2
• 229940030606 diuretics Drugs 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 238000010828 elution Methods 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 229910052731 fluorine Inorganic materials 0.000 description 2
• 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 2
• 125000002168 glycyrrhetinic acid group Chemical group 0.000 description 2
• 229940093915 gynecological organic acid Drugs 0.000 description 2
• 210000002216 heart Anatomy 0.000 description 2
• 125000000592 heterocycloalkyl group Chemical group 0.000 description 2
• 125000004415 heterocyclylalkyl group Chemical group 0.000 description 2
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 150000004677 hydrates Chemical class 0.000 description 2
• 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 2
• 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 2
• 125000002883 imidazolyl group Chemical group 0.000 description 2
• 125000003114 inden-1-yl group Chemical group [H]C1=C([H])C([H])(*)C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• 210000002977 intracellular fluid Anatomy 0.000 description 2
• QZUPTXGVPYNUIT-UHFFFAOYSA-N isophthalamide Chemical compound NC(=O)C1=CC=CC(C(N)=O)=C1 QZUPTXGVPYNUIT-UHFFFAOYSA-N 0.000 description 2
• 208000017169 kidney disease Diseases 0.000 description 2
• 230000003907 kidney function Effects 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 235000019359 magnesium stearate Nutrition 0.000 description 2
• 238000007726 management method Methods 0.000 description 2
• 239000002207 metabolite Substances 0.000 description 2
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
• YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 2
• 239000002395 mineralocorticoid Substances 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 210000000663 muscle cell Anatomy 0.000 description 2
• NXBYTETUXUSMHM-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]-2,3-dihydroxybutanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)C(O)C(O)C(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 NXBYTETUXUSMHM-UHFFFAOYSA-N 0.000 description 2
• SNTWQTFUQNUEKF-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]-2,3-dihydroxybutanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCOCCOCCOCCNC(=O)C(O)C(O)C(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 SNTWQTFUQNUEKF-UHFFFAOYSA-N 0.000 description 2
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 210000002569 neuron Anatomy 0.000 description 2
• 239000012299 nitrogen atmosphere Substances 0.000 description 2
• NMRPBPVERJPACX-UHFFFAOYSA-N octan-3-ol Chemical compound CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 2
• 150000007524 organic acids Chemical class 0.000 description 2
• 235000005985 organic acids Nutrition 0.000 description 2
• 125000002971 oxazolyl group Chemical group 0.000 description 2
• 125000004430 oxygen atom Chemical group O* 0.000 description 2
• 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 2
• SRJOCJYGOFTFLH-UHFFFAOYSA-M piperidine-4-carboxylate Chemical compound [O-]C(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-M 0.000 description 2
• 239000002952 polymeric resin Substances 0.000 description 2
• 229940100467 polyvinyl acetate phthalate Drugs 0.000 description 2
• 208000024896 potassium deficiency disease Diseases 0.000 description 2
• 150000003141 primary amines Chemical class 0.000 description 2
• WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
• 210000000512 proximal kidney tubule Anatomy 0.000 description 2
• 125000003373 pyrazinyl group Chemical group 0.000 description 2
• 125000000714 pyrimidinyl group Chemical group 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• 230000036390 resting membrane potential Effects 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
• 150000003335 secondary amines Chemical class 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 2
• 239000012279 sodium borohydride Substances 0.000 description 2
• 229910000033 sodium borohydride Inorganic materials 0.000 description 2
• 229910000029 sodium carbonate Inorganic materials 0.000 description 2
• 235000017550 sodium carbonate Nutrition 0.000 description 2
• 210000002784 stomach Anatomy 0.000 description 2
• 125000005346 substituted cycloalkyl group Chemical group 0.000 description 2
• FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
• 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
• 230000002195 synergetic effect Effects 0.000 description 2
• 229920003002 synthetic resin Polymers 0.000 description 2
• 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 2
• 150000003536 tetrazoles Chemical class 0.000 description 2
• YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
• 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 2
• 125000000335 thiazolyl group Chemical group 0.000 description 2
• 238000004809 thin layer chromatography Methods 0.000 description 2
• 125000003396 thiol group Chemical class [H]S* 0.000 description 2
• 231100000331 toxic Toxicity 0.000 description 2
• 230000002588 toxic effect Effects 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• 125000004306 triazinyl group Chemical group 0.000 description 2
• 125000001425 triazolyl group Chemical group 0.000 description 2
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
• GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
• YXBAYDMFZYTLJI-HKUYNNGSSA-N (1S,2S)-4,6-dichloro-1-(2,6-dimethylphenoxy)-N,N-dimethyl-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC=1C(=CC=CC=1C)C)N(C)C YXBAYDMFZYTLJI-HKUYNNGSSA-N 0.000 description 1
• LIDYAZKCGFCTGE-IRXDYDNUSA-N (1S,2S)-4,6-dichloro-N,N-dimethyl-1-phenoxy-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=CC=CC=C1)N(C)C LIDYAZKCGFCTGE-IRXDYDNUSA-N 0.000 description 1
• HOAIIKMYWZFQAN-PMACEKPBSA-N (1S,2S)-6-chloro-1-phenoxy-2-piperazin-1-yl-2,3-dihydro-1H-indene-4-carbonitrile Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=CC=CC=C1)N1CCNCC1)C#N HOAIIKMYWZFQAN-PMACEKPBSA-N 0.000 description 1
• FMKSUUOPKFEKFK-WMZOPIPTSA-N (1S,2S)-6-chloro-4-methoxy-N,N-dimethyl-1-phenoxy-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=CC=CC=C1)N(C)C)OC FMKSUUOPKFEKFK-WMZOPIPTSA-N 0.000 description 1
• MTBJVERQKQVBQM-ROUUACIJSA-N (1S,2S)-6-chloro-N,N,4-trimethyl-1-phenoxy-2,3-dihydro-1H-inden-2-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=CC=CC=C1)N(C)C)C MTBJVERQKQVBQM-ROUUACIJSA-N 0.000 description 1
• PTIALSJRKNBZIO-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[2-(2,5-dioxopyrrolidin-1-yl)oxy-2-oxoethoxy]acetate Chemical compound O=C1CCC(=O)N1OC(=O)COCC(=O)ON1C(=O)CCC1=O PTIALSJRKNBZIO-UHFFFAOYSA-N 0.000 description 1
• QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
• UAGFTQCWTTYZKO-PGMHMLKASA-N (2r)-pyrrolidine-2-carboxylic acid;hydrochloride Chemical compound Cl.OC(=O)[C@H]1CCCN1 UAGFTQCWTTYZKO-PGMHMLKASA-N 0.000 description 1
• IURZUEFKSVDRPL-ANIJKYDJSA-N (2r,3r)-n,n'-bis[2-[2-[2-[3-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)anilino]-3-oxopropoxy]ethoxy]ethoxy]ethyl]-2,3-dihydroxybutanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NC(=O)CCOCCOCCOCCNC(=O)[C@H](O)[C@@H](O)C(=O)NCCOCCOCCOCCC(=O)NC=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 IURZUEFKSVDRPL-ANIJKYDJSA-N 0.000 description 1
• ALMVJCXGEFLRBW-OUWJEIDNSA-N (2r,3r)-n,n'-bis[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-2,3-dihydroxybutanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCOCCOCCNC(=O)[C@H](O)[C@@H](O)C(=O)NCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 ALMVJCXGEFLRBW-OUWJEIDNSA-N 0.000 description 1
• QSHCHUOVXBBRRH-UGQFUBBSSA-N (2r,3r)-n,n'-bis[3-[3-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]propyl-methylamino]propyl]-2,3-dihydroxybutanediamide Chemical compound C1N(C)CC2=C(Cl)C=C(Cl)C=C2C1C1=CC(S(=O)(=O)NCCCN(CCCNC(=O)[C@H](O)[C@@H](O)C(=O)NCCCN(C)CCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C)=CC=C1 QSHCHUOVXBBRRH-UGQFUBBSSA-N 0.000 description 1
• NXBYTETUXUSMHM-WPQDHYHXSA-N (2s,3r)-n,n'-bis[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]-2,3-dihydroxybutanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)[C@@H](O)[C@@H](O)C(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 NXBYTETUXUSMHM-WPQDHYHXSA-N 0.000 description 1
• NXBYTETUXUSMHM-MRQUPOCTSA-N (2s,3s)-n,n'-bis[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]-2,3-dihydroxybutanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)[C@@H](O)[C@H](O)C(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 NXBYTETUXUSMHM-MRQUPOCTSA-N 0.000 description 1
• BVFNXPIOAFINAP-HQOQDVMHSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(2,6-difluorophenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=C(C=CC=C1F)F BVFNXPIOAFINAP-HQOQDVMHSA-N 0.000 description 1
• SIGHIWHZULHJDG-MJWYBRSISA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(2-fluorophenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=C(C=CC=C1)F SIGHIWHZULHJDG-MJWYBRSISA-N 0.000 description 1
• WNGRBRAQFYPUKD-UAOJZALGSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(3-fluorophenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=CC(=CC=C1)F WNGRBRAQFYPUKD-UAOJZALGSA-N 0.000 description 1
• KLFDNFBKULUHSP-OREJSRFESA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(3-methoxyphenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=CC(=CC=C1)OC KLFDNFBKULUHSP-OREJSRFESA-N 0.000 description 1
• NKFZGJALYZPWIZ-NQERJWCQSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-(3-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]piperidin-3-amine Chemical compound N[C@H]1CN(CCC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=CC(=CC=C1)C NKFZGJALYZPWIZ-NQERJWCQSA-N 0.000 description 1
• QEVLOPVSANXENE-XGRCMKMKSA-N (3R)-1-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpiperidin-3-amine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=CC=CC=C1)N1C[C@@H](CCC1)N(C)C QEVLOPVSANXENE-XGRCMKMKSA-N 0.000 description 1
• XGCXWKMSPDXJLV-UCFCWBNQSA-N (3R)-1-[(1S,2S)-6-chloro-4-methyl-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpiperidin-3-amine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=C(C=CC=C1)C)N1C[C@@H](CCC1)N(C)C)C XGCXWKMSPDXJLV-UCFCWBNQSA-N 0.000 description 1
• 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
• 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 description 1
• 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 1
• AEOVHDZCULBVSK-KDJFERLWSA-N (E)-N-(diaminomethylidene)-3-[3,5-difluoro-4-[4-[2-[2-[2-[2-[3-[2-[2-[2-(2-propoxyethoxy)ethoxy]ethoxy]ethoxy]propanoylamino]ethoxy]ethoxy]ethoxy]ethylsulfamoyl]phenoxy]phenyl]-2-methylprop-2-enamide Chemical compound CCCOCCOCCOCCOCCOCCC(=O)NCCOCCOCCOCCNS(=O)(=O)C1=CC=C(OC2=C(F)C=C(\C=C(/C)C(=O)N=C(N)N)C=C2F)C=C1 AEOVHDZCULBVSK-KDJFERLWSA-N 0.000 description 1
• BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
• SYSZENVIJHPFNL-UHFFFAOYSA-N (alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform B (protein) Chemical compound COC1=CC=C(I)C=C1 SYSZENVIJHPFNL-UHFFFAOYSA-N 0.000 description 1
• PHPJDFTXBBRTHD-SAPNQHFASA-N (e)-3-[4-[4-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethylsulfamoyl]phenoxy]-3,5-difluorophenyl]-n-(diaminomethylidene)-2-methylprop-2-enamide Chemical compound FC1=CC(\C=C(/C)C(=O)N=C(N)N)=CC(F)=C1OC1=CC=C(S(=O)(=O)NCCOCCOCCOCCN)C=C1 PHPJDFTXBBRTHD-SAPNQHFASA-N 0.000 description 1
• VQSATWNLRLVRSM-BSYVCWPDSA-N (e)-3-[4-[4-[2-[2-[2-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylsulfamoyl]phenoxy]-3,5-difluorophenyl]-n-(diaminomethylidene)-2-methylprop-2-enamide Chemical compound FC1=CC(\C=C(/C)C(=O)N=C(N)N)=CC(F)=C1OC1=CC=C(S(=O)(=O)NCCOCCOCCOCCOCCOCCOCCN)C=C1 VQSATWNLRLVRSM-BSYVCWPDSA-N 0.000 description 1
• 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
• WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
• FQDXJYBXPOMIBX-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-ol Chemical compound FC(F)(F)C(O)(C)C(F)(F)F FQDXJYBXPOMIBX-UHFFFAOYSA-N 0.000 description 1
• 125000001414 1,2,4-triazol-5-yl group Chemical group [H]N1N=C([H])N=C1[*] 0.000 description 1
• GOYDNIKZWGIXJT-UHFFFAOYSA-N 1,2-difluorobenzene Chemical compound FC1=CC=CC=C1F GOYDNIKZWGIXJT-UHFFFAOYSA-N 0.000 description 1
• 125000004522 1,3,4-thiadiazol-5-yl group Chemical group S1C=NN=C1* 0.000 description 1
• SXPBNCPKICHUFU-UHFFFAOYSA-N 1,3-bis[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]urea Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCOCCOCCNC(=O)NCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 SXPBNCPKICHUFU-UHFFFAOYSA-N 0.000 description 1
• PIYNUZCGMLCXKJ-UHFFFAOYSA-N 1,4-dioxane-2,6-dione Chemical compound O=C1COCC(=O)O1 PIYNUZCGMLCXKJ-UHFFFAOYSA-N 0.000 description 1
• 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 1
• PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
• DOWUUKPNSKLBMR-PMACEKPBSA-N 1-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]-4-methylpiperazine Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=CC=CC=C1)N1CCN(CC1)C DOWUUKPNSKLBMR-PMACEKPBSA-N 0.000 description 1
• GTSVLAYDWOCJJK-PMACEKPBSA-N 1-[(1S,2S)-6-chloro-4-methyl-1-phenoxy-2,3-dihydro-1H-inden-2-yl]piperazine Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=CC=CC=C1)N1CCNCC1)C GTSVLAYDWOCJJK-PMACEKPBSA-N 0.000 description 1
• ZPANXMBRBMXECG-UHFFFAOYSA-N 1-[2-[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethylcarbamoyla Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCOCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 ZPANXMBRBMXECG-UHFFFAOYSA-N 0.000 description 1
• DTPBYOCYGDPGQG-UHFFFAOYSA-N 1-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-4-fluorophenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-4-fluorophenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound O=C(NCCOCCOCCNS(=O)(=O)C1=CC(=C(C=C1)F)C1CN(CC2=C(C=C(C=C12)Cl)Cl)C)NCCCCNC(NCCOCCOCCNS(=O)(=O)C1=CC(=C(C=C1)F)C1CN(CC2=C(C=C(C=C12)Cl)Cl)C)=O DTPBYOCYGDPGQG-UHFFFAOYSA-N 0.000 description 1
• QLBMPWRKWVMEPS-UHFFFAOYSA-N 1-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-4-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-4-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound CN1CC(C2=C(C)C=CC(=C2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C2=CC(C3CN(C)CC4=C3C=C(Cl)C=C4Cl)=C(C)C=C2)C2=C(C1)C(Cl)=CC(Cl)=C2 QLBMPWRKWVMEPS-UHFFFAOYSA-N 0.000 description 1
• DNHPDWGIXIMXSA-UHFFFAOYSA-N 1-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 DNHPDWGIXIMXSA-UHFFFAOYSA-N 0.000 description 1
• CSTNAQPBOPARIZ-UHFFFAOYSA-N 1-[2-[2-[2-[[3-(6-chloro-2,8-dimethyl-3,4-dihydro-1H-isoquinolin-4-yl)-4-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[3-(6-chloro-2,8-dimethyl-3,4-dihydro-1H-isoquinolin-4-yl)-4-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound O=C(NCCOCCOCCNS(=O)(=O)C1=CC(=C(C=C1)C)C1CN(CC2=C(C=C(C=C12)Cl)C)C)NCCCCNC(NCCOCCOCCNS(=O)(=O)C1=CC(=C(C=C1)C)C1CN(CC2=C(C=C(C=C12)Cl)C)C)=O CSTNAQPBOPARIZ-UHFFFAOYSA-N 0.000 description 1
• LPOOAIYWJXCQLO-UHFFFAOYSA-N 1-[2-[2-[2-[[3-(6-chloro-2,8-dimethyl-3,4-dihydro-1H-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[3-(6-chloro-2,8-dimethyl-3,4-dihydro-1H-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound O=C(NCCOCCOCCNS(=O)(=O)C1=CC(=CC=C1)C1CN(CC2=C(C=C(C=C12)Cl)C)C)NCCCCNC(NCCOCCOCCNS(=O)(=O)C1=CC(=CC=C1)C1CN(CC2=C(C=C(C=C12)Cl)C)C)=O LPOOAIYWJXCQLO-UHFFFAOYSA-N 0.000 description 1
• JQJNCRYEIZDJMD-UHFFFAOYSA-N 1-[2-[2-[2-[[3-(6-chloro-8-cyano-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-4-fluorophenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[3-(6-chloro-8-cyano-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-4-fluorophenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound O=C(NCCOCCOCCNS(=O)(=O)C1=CC(=C(C=C1)F)C1CN(CC2=C(C=C(C=C12)Cl)C#N)C)NCCCCNC(NCCOCCOCCNS(=O)(=O)C1=CC(=C(C=C1)F)C1CN(CC2=C(C=C(C=C12)Cl)C#N)C)=O JQJNCRYEIZDJMD-UHFFFAOYSA-N 0.000 description 1
• FVAPOYPJYNUIPS-UHFFFAOYSA-N 1-[2-[2-[2-[[3-(6-chloro-8-cyano-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-4-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[3-(6-chloro-8-cyano-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-4-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound CN1CC(C2=C(C)C=CC(=C2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C2=CC(C3CN(C)CC4=C3C=C(Cl)C=C4C#N)=C(C)C=C2)C2=C(C1)C(=CC(Cl)=C2)C#N FVAPOYPJYNUIPS-UHFFFAOYSA-N 0.000 description 1
• RYXAQGKLQHUUBT-UHFFFAOYSA-N 1-[2-[2-[2-[[3-(6-chloro-8-cyano-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[3-(6-chloro-8-cyano-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound O=C(NCCOCCOCCNS(=O)(=O)C1=CC(=CC=C1)C1CN(CC2=C(C=C(C=C12)Cl)C#N)C)NCCCCNC(NCCOCCOCCNS(=O)(=O)C1=CC(=CC=C1)C1CN(CC2=C(C=C(C=C12)Cl)C#N)C)=O RYXAQGKLQHUUBT-UHFFFAOYSA-N 0.000 description 1
• KHUQLCGKBYSOOQ-UHFFFAOYSA-N 1-[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 KHUQLCGKBYSOOQ-UHFFFAOYSA-N 0.000 description 1
• INJBESAYBAGURN-UHFFFAOYSA-N 1-[2-[2-[2-[[5-(6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-2-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[5-(6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-2-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound CN1CC(C2=CC(=C(C)C=C2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C2=C(C)C=CC(=C2)C2CN(C)CC3=C2C=C(Cl)C=C3Cl)C2=C(C1)C(Cl)=CC(Cl)=C2 INJBESAYBAGURN-UHFFFAOYSA-N 0.000 description 1
• BUZIFTBLDVYRMI-UHFFFAOYSA-N 1-[2-[2-[2-[[5-(6-chloro-2,8-dimethyl-3,4-dihydro-1H-isoquinolin-4-yl)-2-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[5-(6-chloro-2,8-dimethyl-3,4-dihydro-1H-isoquinolin-4-yl)-2-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound O=C(NCCOCCOCCNS(=O)(=O)C1=C(C=CC(=C1)C1CN(CC2=C(C=C(C=C12)Cl)C)C)C)NCCCCNC(NCCOCCOCCNS(=O)(=O)C1=C(C=CC(=C1)C1CN(CC2=C(C=C(C=C12)Cl)C)C)C)=O BUZIFTBLDVYRMI-UHFFFAOYSA-N 0.000 description 1
• VEAGHRMIVKHJKV-UHFFFAOYSA-N 1-[2-[2-[2-[[5-(6-chloro-8-cyano-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-2-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[5-(6-chloro-8-cyano-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)-2-methylphenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound O=C(NCCOCCOCCNS(=O)(=O)C1=C(C=CC(=C1)C1CN(CC2=C(C=C(C=C12)Cl)C#N)C)C)NCCCCNC(NCCOCCOCCNS(=O)(=O)C1=C(C=CC(=C1)C1CN(CC2=C(C=C(C=C12)Cl)C#N)C)C)=O VEAGHRMIVKHJKV-UHFFFAOYSA-N 0.000 description 1
• MFEYKTFDWOKBTD-GQYFIECQSA-N 1-[2-[2-[5-[[(1S,2S)-6-chloro-4-cyano-2-piperazin-1-yl-2,3-dihydro-1H-inden-1-yl]oxy]-3-oxo-1H-isoindol-2-yl]ethoxy]ethyl]-3-[4-[2-[2-[5-[[(1S,2S)-6-chloro-4-cyano-2-piperazin-1-yl-2,3-dihydro-1H-inden-1-yl]oxy]-3-oxo-1H-isoindol-2-yl]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound C(CCCNC(=O)NCCOCCN1C(C2=CC(=CC=C2C1)O[C@@H]1[C@H](CC2=C(C=C(C=C12)Cl)C#N)N1CCNCC1)=O)NC(=O)NCCOCCN1C(C2=CC(=CC=C2C1)O[C@@H]1[C@H](CC2=C(C=C(C=C12)Cl)C#N)N1CCNCC1)=O MFEYKTFDWOKBTD-GQYFIECQSA-N 0.000 description 1
• FNDWNQPEDHELCN-GQYFIECQSA-N 1-[2-[2-[6-[[(1S,2S)-6-chloro-4-cyano-2-piperazin-1-yl-2,3-dihydro-1H-inden-1-yl]oxy]-3-oxo-1H-isoindol-2-yl]ethoxy]ethyl]-3-[4-[2-[2-[6-[[(1S,2S)-6-chloro-4-cyano-2-piperazin-1-yl-2,3-dihydro-1H-inden-1-yl]oxy]-3-oxo-1H-isoindol-2-yl]ethoxy]ethylcarbamoylamino]butyl]urea Chemical compound C(CCCNC(=O)NCCOCCN1C(C2=CC=C(C=C2C1)O[C@@H]1[C@H](CC2=C(C=C(C=C12)Cl)C#N)N1CCNCC1)=O)NC(=O)NCCOCCN1C(C2=CC=C(C=C2C1)O[C@@H]1[C@H](CC2=C(C=C(C=C12)Cl)C#N)N1CCNCC1)=O FNDWNQPEDHELCN-GQYFIECQSA-N 0.000 description 1
• NVDYQIUHDCWXHG-SFTDATJTSA-N 1-[4-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]piperazin-1-yl]ethanone Chemical compound C(C)(=O)N1CCN(CC1)[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=CC=CC=C1 NVDYQIUHDCWXHG-SFTDATJTSA-N 0.000 description 1
• RTXFYPTVYCPPNJ-UHFFFAOYSA-N 1-carbamimidoyl-3-cyano-1-(diaminomethylideneamino)-3-nitrourea Chemical compound NC(=N)NN(C(N)=N)C(=O)N(C#N)[N+]([O-])=O RTXFYPTVYCPPNJ-UHFFFAOYSA-N 0.000 description 1
• XPTPAIJDVFQPJT-UHFFFAOYSA-N 1-chloroethyl propan-2-yl carbonate Chemical compound CC(C)OC(=O)OC(C)Cl XPTPAIJDVFQPJT-UHFFFAOYSA-N 0.000 description 1
• FWZJTQPVXZIABW-UHFFFAOYSA-N 1-methoxy-2-(1-methoxypropan-2-yloxy)propane Chemical compound COCC(C)OC(C)COC FWZJTQPVXZIABW-UHFFFAOYSA-N 0.000 description 1
• GMXBFKAFQKQQRL-UHFFFAOYSA-N 1-n,2-n-bis[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]benzene-1,2-dicarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)C=2C(=CC=CC=2)C(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 GMXBFKAFQKQQRL-UHFFFAOYSA-N 0.000 description 1
• RAZLNJQLUOYEFI-UHFFFAOYSA-N 1-n,3-n-bis[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]benzene-1,3-disulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)S(=O)(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 RAZLNJQLUOYEFI-UHFFFAOYSA-N 0.000 description 1
• CLKWCQHHISBZCZ-UHFFFAOYSA-N 1-n,3-n-bis[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-5-hydroxybenzene-1,3-dicarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCOCCOCCNC(=O)C=2C=C(C=C(O)C=2)C(=O)NCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 CLKWCQHHISBZCZ-UHFFFAOYSA-N 0.000 description 1
• NMZATJZWHZOUID-UHFFFAOYSA-N 1-n,4-n-bis[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]benzene-1,4-dicarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)C=2C=CC(=CC=2)C(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 NMZATJZWHZOUID-UHFFFAOYSA-N 0.000 description 1
• GFNIFQOPNUJPDY-UHFFFAOYSA-N 1-n,4-n-bis[2-[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]benzene-1,4-dicarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCOCCOCCOCCNC(=O)C=2C=CC(=CC=2)C(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 GFNIFQOPNUJPDY-UHFFFAOYSA-N 0.000 description 1
• NHIXKUDRYQFGKB-UHFFFAOYSA-N 1-n,4-n-bis[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]benzene-1,4-dicarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCNC(=O)C=2C=CC(=CC=2)C(=O)NCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 NHIXKUDRYQFGKB-UHFFFAOYSA-N 0.000 description 1
• ATGXRRRNBUEJRN-UHFFFAOYSA-N 1-n,4-n-bis[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]benzene-1,4-dicarboxamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCOCCOCCNC(=O)C=2C=CC(=CC=2)C(=O)NCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 ATGXRRRNBUEJRN-UHFFFAOYSA-N 0.000 description 1
• 102000006739 11-beta-Hydroxysteroid Dehydrogenase Type 2 Human genes 0.000 description 1
• 108010086356 11-beta-Hydroxysteroid Dehydrogenase Type 2 Proteins 0.000 description 1
• 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
• VUAXHMVRKOTJKP-UHFFFAOYSA-N 2,2-dimethylbutyric acid Chemical compound CCC(C)(C)C(O)=O VUAXHMVRKOTJKP-UHFFFAOYSA-N 0.000 description 1
• SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
• 125000006516 2-(benzyloxy)ethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
• BPXKZEMBEZGUAH-UHFFFAOYSA-N 2-(chloromethoxy)ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCCl BPXKZEMBEZGUAH-UHFFFAOYSA-N 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
• OBJIYMMRGMSTJW-UHFFFAOYSA-N 2-[(2,4-dichlorophenyl)methyl-methylamino]-1-(3-nitrophenyl)ethanone Chemical compound C=1C=C(Cl)C=C(Cl)C=1CN(C)CC(=O)C1=CC=CC([N+]([O-])=O)=C1 OBJIYMMRGMSTJW-UHFFFAOYSA-N 0.000 description 1
• NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
• ZYHQGITXIJDDKC-UHFFFAOYSA-N 2-[2-(2-aminophenyl)ethyl]aniline Chemical group NC1=CC=CC=C1CCC1=CC=CC=C1N ZYHQGITXIJDDKC-UHFFFAOYSA-N 0.000 description 1
• OKUWOEKJQRUMBW-UHFFFAOYSA-N 2-[2-(2-methoxyethoxy)ethoxy]ethanamine Chemical compound COCCOCCOCCN OKUWOEKJQRUMBW-UHFFFAOYSA-N 0.000 description 1
• IIAFEYNFBCSAQK-UHFFFAOYSA-N 2-[[2-[[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]acetyl]amino]acetyl]amino]-n-[4-[[2-[[2-[[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]acetyl]amino]acetyl]amino]acetyl]amino]bu Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCC(=O)NCC(=O)NCC(=O)NCCCCNC(=O)CNC(=O)CNC(=O)CNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 IIAFEYNFBCSAQK-UHFFFAOYSA-N 0.000 description 1
• XZUNIHOKJSCYRM-UHFFFAOYSA-N 2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfamoylamino]ethylphosphonic acid Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(NS(=O)(=O)NCCP(O)(O)=O)C=C1 XZUNIHOKJSCYRM-UHFFFAOYSA-N 0.000 description 1
• YTTWRATYDRXVHX-UHFFFAOYSA-N 2-[bis[2-[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethyl]amino]-n-[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]et Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)CN(CC(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)CC(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 YTTWRATYDRXVHX-UHFFFAOYSA-N 0.000 description 1
• MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
• 125000000979 2-amino-2-oxoethyl group Chemical group [H]C([*])([H])C(=O)N([H])[H] 0.000 description 1
• 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
• CQQUWTMMFMJEFE-UHFFFAOYSA-N 2-chloro-n,n-diethylacetamide Chemical compound CCN(CC)C(=O)CCl CQQUWTMMFMJEFE-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• 229940013085 2-diethylaminoethanol Drugs 0.000 description 1
• 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
• AMSDWLOANMAILF-UHFFFAOYSA-N 2-imidazol-1-ylethanol Chemical compound OCCN1C=CN=C1 AMSDWLOANMAILF-UHFFFAOYSA-N 0.000 description 1
• 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
• 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• 125000005916 2-methylpentyl group Chemical group 0.000 description 1
• ZQXSFZAMFNRZOQ-UHFFFAOYSA-N 2-methylpropan-2-ol;hydrate Chemical compound O.CC(C)(C)O ZQXSFZAMFNRZOQ-UHFFFAOYSA-N 0.000 description 1
• WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
• CUZKCNWZBXLAJX-UHFFFAOYSA-N 2-phenylmethoxyethanol Chemical compound OCCOCC1=CC=CC=C1 CUZKCNWZBXLAJX-UHFFFAOYSA-N 0.000 description 1
• 125000001698 2H-pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
• 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
• 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
• 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
• DTDSRPFFMIHIQE-UHFFFAOYSA-N 3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-[12-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]dodecyl]benzenesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCCCCCCCCCCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 DTDSRPFFMIHIQE-UHFFFAOYSA-N 0.000 description 1
• YZUIQZXPUDYVJW-UHFFFAOYSA-N 3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-[2-[2-[2-[2-[[4-[4-[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethylsulfamoyl]phenyl]phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C=2C=CC(=CC=2)S(=O)(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 YZUIQZXPUDYVJW-UHFFFAOYSA-N 0.000 description 1
• WDKAVWZCKWSHDW-UHFFFAOYSA-N 3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-[4-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]butyl]benzenesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 WDKAVWZCKWSHDW-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 1
• NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
• 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
• 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 1
• ZFYWXMJNWOVLMZ-UHFFFAOYSA-N 3-methoxy-2,2-dimethyl-3-oxopropanoic acid Chemical compound COC(=O)C(C)(C)C(O)=O ZFYWXMJNWOVLMZ-UHFFFAOYSA-N 0.000 description 1
• 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
• 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
• 125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
• ZXIJAJRJFUMBAO-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-[12-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]dodecyl]benzenesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCCCCCCCCCCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 ZXIJAJRJFUMBAO-UHFFFAOYSA-N 0.000 description 1
• OPWVKBOBJFJYKT-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-[4-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]butyl]benzenesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 OPWVKBOBJFJYKT-UHFFFAOYSA-N 0.000 description 1
• IDEVYONHJOPOKE-UHFFFAOYSA-N 4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)-n-[[4-[[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]methyl]phenyl]methyl]benzenesulfonamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCC=2C=CC(CNS(=O)(=O)C=3C=CC(=CC=3)C3C4=CC(Cl)=CC(Cl)=C4CN(C)C3)=CC=2)C=C1 IDEVYONHJOPOKE-UHFFFAOYSA-N 0.000 description 1
• DPBWFNDFMCCGGJ-UHFFFAOYSA-N 4-Piperidine carboxamide Chemical compound NC(=O)C1CCNCC1 DPBWFNDFMCCGGJ-UHFFFAOYSA-N 0.000 description 1
• HDJTYIBIGHHQBV-UNMCSNQZSA-N 4-[(1S,2S)-4,6-dichloro-1-(2-methylphenoxy)-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpiperazine-1-carboxamide Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=C(C=CC=C1)C)N1CCN(CC1)C(N(C)C)=O HDJTYIBIGHHQBV-UNMCSNQZSA-N 0.000 description 1
• JJJHHKWBIXYOKT-SFTDATJTSA-N 4-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpiperazine-1-carboxamide Chemical compound ClC1=C2C[C@@H]([C@H](C2=CC(=C1)Cl)OC1=CC=CC=C1)N1CCN(CC1)C(N(C)C)=O JJJHHKWBIXYOKT-SFTDATJTSA-N 0.000 description 1
• QGMGHALXLXKCBD-UHFFFAOYSA-N 4-amino-n-(2-aminophenyl)benzamide Chemical compound C1=CC(N)=CC=C1C(=O)NC1=CC=CC=C1N QGMGHALXLXKCBD-UHFFFAOYSA-N 0.000 description 1
• 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
• 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
• 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
• NENLLFGJFVVZEU-UHFFFAOYSA-N 4-methoxy-3,3-dimethyl-4-oxobutanoic acid Chemical compound COC(=O)C(C)(C)CC(O)=O NENLLFGJFVVZEU-UHFFFAOYSA-N 0.000 description 1
• 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
• 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
• 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
• 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
• VRHDGNGUBCUXSG-HFWVJFOYSA-N 9-[(1S,2S)-4,6-dichloro-1-phenoxy-2,3-dihydro-1H-inden-2-yl]-9-azabicyclo[3.3.1]nonane Chemical compound C12CCCC(CCC1)N2[C@@H]1[C@H](C2=CC(=CC(=C2C1)Cl)Cl)OC1=CC=CC=C1 VRHDGNGUBCUXSG-HFWVJFOYSA-N 0.000 description 1
• 108091006112 ATPases Proteins 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
• PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
• PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
• KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
• 101100439664 Arabidopsis thaliana CHR8 gene Proteins 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• JXYACYYPACQCDM-UHFFFAOYSA-N Benzyl glycinate Chemical compound NCC(=O)OCC1=CC=CC=C1 JXYACYYPACQCDM-UHFFFAOYSA-N 0.000 description 1
• KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
• UCZSADCRJSMICA-UHFFFAOYSA-N C(CCC(=O)O)(=O)OCCCO.C(C)(=O)O Chemical compound C(CCC(=O)O)(=O)OCCCO.C(C)(=O)O UCZSADCRJSMICA-UHFFFAOYSA-N 0.000 description 1
• FQBGXZIZFIPGBO-UHFFFAOYSA-N CC(C)(C(CCC1(C)C(C)(CCC(C)(CC2)C3CC2(C)C(O)=O)C3=C2)C(C)(CC3)C1C2=O)C3OCC(CNCC(OCC1=CC=CC=C1)=O)O Chemical compound CC(C)(C(CCC1(C)C(C)(CCC(C)(CC2)C3CC2(C)C(O)=O)C3=C2)C(C)(CC3)C1C2=O)C3OCC(CNCC(OCC1=CC=CC=C1)=O)O FQBGXZIZFIPGBO-UHFFFAOYSA-N 0.000 description 1
• AQZOKMZZLMRUDJ-UHFFFAOYSA-N CC(C)(C(CCC1(C)C(C)(CCC(C)(CC2)C3CC2(C)C(O)=O)C3=C2)C(C)(CC3)C1C2=O)C3OCC(OC)=O Chemical compound CC(C)(C(CCC1(C)C(C)(CCC(C)(CC2)C3CC2(C)C(O)=O)C3=C2)C(C)(CC3)C1C2=O)C3OCC(OC)=O AQZOKMZZLMRUDJ-UHFFFAOYSA-N 0.000 description 1
• LQQDPDSBLBHMMQ-OIAFPMCFSA-N C[C@@H](CC[C@@]1(C)CC[C@@]2(C)[C@](C)(CC3)[C@H]4[C@@](C)(CC5)[C@@H]3C(C)(C)[C@H]5OCC(OC)=O)C[C@H]1C2=CC4=O Chemical compound C[C@@H](CC[C@@]1(C)CC[C@@]2(C)[C@](C)(CC3)[C@H]4[C@@](C)(CC5)[C@@H]3C(C)(C)[C@H]5OCC(OC)=O)C[C@H]1C2=CC4=O LQQDPDSBLBHMMQ-OIAFPMCFSA-N 0.000 description 1
• KQSWXKKHYRGXFN-KATYLOTRSA-N C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H]([C@@]([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C(=O)O)O)C)(C)C(=O)O Chemical compound C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H]([C@@]([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C(=O)O)O)C)(C)C(=O)O KQSWXKKHYRGXFN-KATYLOTRSA-N 0.000 description 1
• BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 229930186147 Cephalosporin Natural products 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
• 206010010774 Constipation Diseases 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 229920002785 Croscarmellose sodium Polymers 0.000 description 1
• RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
• RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 241000305071 Enterobacterales Species 0.000 description 1
• PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
• 229920003135 Eudragit® L 100-55 Polymers 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
• 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
• 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
• 102100022662 Guanylyl cyclase C Human genes 0.000 description 1
• 101710198293 Guanylyl cyclase C Proteins 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• 206010024264 Lethargy Diseases 0.000 description 1
• 229910010084 LiAlH4 Inorganic materials 0.000 description 1
• VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• UUIQMZJEGPQKFD-UHFFFAOYSA-N Methyl butyrate Chemical compound CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 description 1
• KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
• BMXLXZLZGLGHJC-CRKOEVGVSA-N N-[1-[3-[(4S)-6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl]phenyl]sulfonylpiperidin-4-yl]-4-[4-[[4-[[1-[3-[(4S)-6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl]phenyl]sulfonylpiperidin-4-yl]amino]-4-oxobutyl]carbamoylamino]butylcarbamoylamino]butanamide Chemical compound ClC=1C=C2[C@@H](CN(CC2=C(C=1)Cl)C)C=1C=C(C=CC=1)S(=O)(=O)N1CCC(CC1)NC(CCCNC(NCCCCNC(NCCCC(=O)NC1CCN(CC1)S(=O)(=O)C1=CC(=CC=C1)[C@@H]1CN(CC2=C(C=C(C=C12)Cl)Cl)C)=O)=O)=O BMXLXZLZGLGHJC-CRKOEVGVSA-N 0.000 description 1
• RCUGXPLZFMUQSF-PJYGOTMFSA-N N-[1-[3-[(4S)-6-chloro-2,8-dimethyl-3,4-dihydro-1H-isoquinolin-4-yl]phenyl]sulfonylpiperidin-4-yl]-4-[4-[[4-[[1-[3-[(4S)-6-chloro-2,8-dimethyl-3,4-dihydro-1H-isoquinolin-4-yl]phenyl]sulfonylpiperidin-4-yl]amino]-4-oxobutyl]carbamoylamino]butylcarbamoylamino]butanamide Chemical compound ClC=1C=C2[C@@H](CN(CC2=C(C=1)C)C)C=1C=C(C=CC=1)S(=O)(=O)N1CCC(CC1)NC(CCCNC(NCCCCNC(NCCCC(=O)NC1CCN(CC1)S(=O)(=O)C1=CC(=CC=C1)[C@@H]1CN(CC2=C(C=C(C=C12)Cl)C)C)=O)=O)=O RCUGXPLZFMUQSF-PJYGOTMFSA-N 0.000 description 1
• JWJQSNLCTZHYDJ-XWQGWOARSA-N N-[1-[3-[(4S)-6-chloro-8-cyano-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl]phenyl]sulfonylpiperidin-4-yl]-4-[4-[[4-[[1-[3-[(4S)-6-chloro-8-cyano-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl]phenyl]sulfonylpiperidin-4-yl]amino]-4-oxobutyl]carbamoylamino]butylcarbamoylamino]butanamide Chemical compound ClC=1C=C2[C@@H](CN(CC2=C(C=1)C#N)C)C=1C=C(C=CC=1)S(=O)(=O)N1CCC(CC1)NC(CCCNC(NCCCCNC(NCCCC(=O)NC1CCN(CC1)S(=O)(=O)C1=CC(=CC=C1)[C@@H]1CN(CC2=C(C=C(C=C12)Cl)C#N)C)=O)=O)=O JWJQSNLCTZHYDJ-XWQGWOARSA-N 0.000 description 1
• XZKAIRYHWCWTOM-WIEITHNNSA-N N-[1-[4-[[(1S,2S)-6-chloro-4-cyano-2-piperazin-1-yl-2,3-dihydro-1H-inden-1-yl]oxy]phenyl]sulfonylpiperidin-4-yl]-4-[4-[[4-[[1-[4-[[(1S,2S)-6-chloro-4-cyano-2-piperazin-1-yl-2,3-dihydro-1H-inden-1-yl]oxy]phenyl]sulfonylpiperidin-4-yl]amino]-4-oxobutyl]carbamoylamino]butylcarbamoylamino]butanamide Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=CC=C(C=C1)S(=O)(=O)N1CCC(CC1)NC(CCCNC(NCCCCNC(NCCCC(=O)NC1CCN(CC1)S(=O)(=O)C1=CC=C(C=C1)O[C@@H]1[C@H](CC2=C(C=C(C=C12)Cl)C#N)N1CCNCC1)=O)=O)=O)N1CCNCC1)C#N XZKAIRYHWCWTOM-WIEITHNNSA-N 0.000 description 1
• CFVAWZOLEXOSMW-JOCHJYFZSA-N N-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethyl]-3-[(4R)-6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl]benzenesulfonamide Chemical compound C1([C@H]2CN(CC3=C(Cl)C=C(Cl)C=C32)C)=CC=CC(S(=O)(=O)NCCOCCOCCOCCN=[N+]=[N-])=C1 CFVAWZOLEXOSMW-JOCHJYFZSA-N 0.000 description 1
• CFVAWZOLEXOSMW-QFIPXVFZSA-N N-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethyl]-3-[(4S)-6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl]benzenesulfonamide Chemical compound CN1C[C@@H](c2cccc(c2)S(=O)(=O)NCCOCCOCCOCCN=[N+]=[N-])c2cc(Cl)cc(Cl)c2C1 CFVAWZOLEXOSMW-QFIPXVFZSA-N 0.000 description 1
• FTAZCCXTMKAKDQ-QFIPXVFZSA-N N-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethyl]-4-[(4S)-6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl]benzenesulfonamide Chemical compound C1([C@@H]2CN(CC3=C(Cl)C=C(Cl)C=C32)C)=CC=C(S(=O)(=O)NCCOCCOCCOCCN=[N+]=[N-])C=C1 FTAZCCXTMKAKDQ-QFIPXVFZSA-N 0.000 description 1
• KUZXNLSREFDHRY-SOYKGTTHSA-N N-[2-[2-[2-[2-[2-[2-[2-[[4-[4-[(E)-3-(diaminomethylideneamino)-2-methyl-3-oxoprop-1-enyl]-2,6-difluorophenoxy]phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]-N'-(2-ethoxyethyl)-2,3-dihydroxybutanediamide Chemical compound CCOCCNC(=O)C(O)C(O)C(=O)NCCOCCOCCOCCOCCOCCOCCNS(=O)(=O)c1ccc(Oc2c(F)cc(\C=C(/C)C(=O)N=C(N)N)cc2F)cc1 KUZXNLSREFDHRY-SOYKGTTHSA-N 0.000 description 1
• SRWHNELSDQJLJM-UHFFFAOYSA-N N-[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]-3-[2-[2-[2-(2-ethoxyethoxy)ethoxy]ethoxy]ethoxy]propanamide Chemical compound CCOCCOCCOCCOCCOCCC(=O)NCCOCCOCCOCCNS(=O)(=O)c1cccc(c1)C1CN(C)Cc2c(Cl)cc(Cl)cc12 SRWHNELSDQJLJM-UHFFFAOYSA-N 0.000 description 1
• DQPJQYRFCODFSV-UHFFFAOYSA-N N-[2-[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]-3-[2-[2-[2-(2-ethoxyethoxy)ethoxy]ethoxy]ethoxy]propanamide Chemical compound CCOCCOCCOCCOCCOCCC(=O)NCCOCCOCCOCCNS(=O)(=O)C1=CC=C(C=C1)C1CN(C)CC2=C(Cl)C=C(Cl)C=C12 DQPJQYRFCODFSV-UHFFFAOYSA-N 0.000 description 1
• FDDKROKDDXUDCV-UCKODPIDSA-N N-[4-[[(1S,2S)-6-chloro-4-cyano-2-piperazin-1-yl-2,3-dihydro-1H-inden-1-yl]oxy]phenyl]sulfonyl-4-[4-[[4-[[4-[[(1S,2S)-6-chloro-4-cyano-2-piperazin-1-yl-2,3-dihydro-1H-inden-1-yl]oxy]phenyl]sulfonylamino]-4-oxobutyl]carbamoylamino]butylcarbamoylamino]butanamide Chemical compound ClC1=CC(=C2C[C@@H]([C@H](C2=C1)OC1=CC=C(C=C1)S(=O)(=O)NC(CCCNC(NCCCCNC(NCCCC(=O)NS(=O)(=O)C1=CC=C(C=C1)O[C@@H]1[C@H](CC2=C(C=C(C=C12)Cl)C#N)N1CCNCC1)=O)=O)=O)N1CCNCC1)C#N FDDKROKDDXUDCV-UCKODPIDSA-N 0.000 description 1
• HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
• FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
• MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
• 238000005481 NMR spectroscopy Methods 0.000 description 1
• 101150003511 NR3C2 gene Proteins 0.000 description 1
• 229910003244 Na2PdCl4 Inorganic materials 0.000 description 1
• 206010028813 Nausea Diseases 0.000 description 1
• 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• 239000006057 Non-nutritive feed additive Substances 0.000 description 1
• 206010030113 Oedema Diseases 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
• 102100028255 Renin Human genes 0.000 description 1
• 108090000783 Renin Proteins 0.000 description 1
• 206010039020 Rhabdomyolysis Diseases 0.000 description 1
• 108010077895 Sarcosine Proteins 0.000 description 1
• 229920001800 Shellac Polymers 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
• FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 102000052126 Sodium-Hydrogen Exchangers Human genes 0.000 description 1
• 108091006672 Sodium–hydrogen antiporter Proteins 0.000 description 1
• 229920002125 Sokalan® Polymers 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• 229910010062 TiCl3 Inorganic materials 0.000 description 1
• OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
• 206010047700 Vomiting Diseases 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• AMNPXXIGUOKIPP-UHFFFAOYSA-N [4-(carbamothioylamino)phenyl]thiourea Chemical compound NC(=S)NC1=CC=C(NC(N)=S)C=C1 AMNPXXIGUOKIPP-UHFFFAOYSA-N 0.000 description 1
• UJIDKYTZIQTXPM-UHFFFAOYSA-N [4-[pyridin-2-yl-(4-sulfooxyphenyl)methyl]phenyl] hydrogen sulfate Chemical group C1=CC(OS(=O)(=O)O)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS(O)(=O)=O)C=C1 UJIDKYTZIQTXPM-UHFFFAOYSA-N 0.000 description 1
• XAKBSHICSHRJCL-UHFFFAOYSA-N [CH2]C(=O)C1=CC=CC=C1 Chemical group [CH2]C(=O)C1=CC=CC=C1 XAKBSHICSHRJCL-UHFFFAOYSA-N 0.000 description 1
• AMVVEDHCBDQBJL-UHFFFAOYSA-N [Ca][Zr] Chemical compound [Ca][Zr] AMVVEDHCBDQBJL-UHFFFAOYSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• 239000008351 acetate buffer Substances 0.000 description 1
• 235000011054 acetic acid Nutrition 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 description 1
• 230000036982 action potential Effects 0.000 description 1
• 230000009056 active transport Effects 0.000 description 1
• 125000004442 acylamino group Chemical group 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 210000003486 adipose tissue brown Anatomy 0.000 description 1
• 238000013019 agitation Methods 0.000 description 1
• NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
• 125000006323 alkenyl amino group Chemical group 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 125000005083 alkoxyalkoxy group Chemical group 0.000 description 1
• 150000003973 alkyl amines Chemical class 0.000 description 1
• 125000003282 alkyl amino group Chemical group 0.000 description 1
• 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
• 125000005154 alkyl sulfonyl amino alkyl group Chemical group 0.000 description 1
• 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
• 125000004414 alkyl thio group Chemical group 0.000 description 1
• BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
• 125000005336 allyloxy group Chemical group 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 150000001409 amidines Chemical class 0.000 description 1
• 229960004977 anhydrous lactose Drugs 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 150000003974 aralkylamines Chemical class 0.000 description 1
• 125000005140 aralkylsulfonyl group Chemical group 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 229960003121 arginine Drugs 0.000 description 1
• 150000004982 aromatic amines Chemical class 0.000 description 1
• 125000003435 aroyl group Chemical group 0.000 description 1
• 206010003119 arrhythmia Diseases 0.000 description 1
• 230000006793 arrhythmia Effects 0.000 description 1
• 125000005163 aryl sulfanyl group Chemical group 0.000 description 1
• 125000005135 aryl sulfinyl group Chemical group 0.000 description 1
• 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
• 210000003567 ascitic fluid Anatomy 0.000 description 1
• 229940072107 ascorbate Drugs 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• WXWQVSOHWXJBDF-UHFFFAOYSA-N benzene-1,3,5-tricarboxamide Chemical compound NC(=O)C1=CC(C(N)=O)=CC(C(N)=O)=C1 WXWQVSOHWXJBDF-UHFFFAOYSA-N 0.000 description 1
• 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
• 125000004190 benzothiazol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N=C(*)SC2=C1[H] 0.000 description 1
• 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
• 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
• 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
• 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
• OPAYAQMFPGDUKW-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1.CC(=O)OCC1=CC=CC=C1 OPAYAQMFPGDUKW-UHFFFAOYSA-N 0.000 description 1
• AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
• 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
• 229940125388 beta agonist Drugs 0.000 description 1
• MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 229960003237 betaine Drugs 0.000 description 1
• 239000004305 biphenyl Substances 0.000 description 1
• 235000010290 biphenyl Nutrition 0.000 description 1
• ZSNFGVQUPMRCIP-UHFFFAOYSA-N bis(2,5-dioxopyrrolidin-1-yl) butanedioate Chemical compound O=C1CCC(=O)N1OC(=O)CCC(=O)ON1C(=O)CCC1=O ZSNFGVQUPMRCIP-UHFFFAOYSA-N 0.000 description 1
• 229960000503 bisacodyl Drugs 0.000 description 1
• 230000036772 blood pressure Effects 0.000 description 1
• 229910052794 bromium Inorganic materials 0.000 description 1
• 125000005997 bromomethyl group Chemical group 0.000 description 1
• 230000003139 buffering effect Effects 0.000 description 1
• DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 description 1
• SNCZNSNPXMPCGN-UHFFFAOYSA-N butanediamide Chemical compound NC(=O)CCC(N)=O SNCZNSNPXMPCGN-UHFFFAOYSA-N 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• 229910000024 caesium carbonate Inorganic materials 0.000 description 1
• 229910001424 calcium ion Inorganic materials 0.000 description 1
• 239000000378 calcium silicate Substances 0.000 description 1
• 229910052918 calcium silicate Inorganic materials 0.000 description 1
• PUQLFUHLKNBKQQ-UHFFFAOYSA-L calcium;trifluoromethanesulfonate Chemical compound [Ca+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F PUQLFUHLKNBKQQ-UHFFFAOYSA-L 0.000 description 1
• 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
• 125000002837 carbocyclic group Chemical group 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
• MIURHJCJPVLLHQ-UHFFFAOYSA-N carbonic acid;chloromethane Chemical compound ClC.OC(O)=O MIURHJCJPVLLHQ-UHFFFAOYSA-N 0.000 description 1
• 150000007942 carboxylates Chemical group 0.000 description 1
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
• 230000000747 cardiac effect Effects 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• UOCJDOLVGGIYIQ-PBFPGSCMSA-N cefatrizine Chemical group S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)[C@H](N)C=2C=CC(O)=CC=2)CC=1CSC=1C=NNN=1 UOCJDOLVGGIYIQ-PBFPGSCMSA-N 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 229940124587 cephalosporin Drugs 0.000 description 1
• 150000001780 cephalosporins Chemical class 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 238000004296 chiral HPLC Methods 0.000 description 1
• VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 1
• GGRHYQCXXYLUTL-UHFFFAOYSA-N chloromethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCl GGRHYQCXXYLUTL-UHFFFAOYSA-N 0.000 description 1
• 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 235000013985 cinnamic acid Nutrition 0.000 description 1
• 229930016911 cinnamic acid Natural products 0.000 description 1
• 235000015165 citric acid Nutrition 0.000 description 1
• 230000008045 co-localization Effects 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 235000009508 confectionery Nutrition 0.000 description 1
• 230000008602 contraction Effects 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 229960001681 croscarmellose sodium Drugs 0.000 description 1
• 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
• 239000010779 crude oil Substances 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• 125000004802 cyanophenyl group Chemical group 0.000 description 1
• 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 1
• 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
• 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
• 210000000172 cytosol Anatomy 0.000 description 1
• 230000007423 decrease Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 238000009110 definitive therapy Methods 0.000 description 1
• 239000000412 dendrimer Substances 0.000 description 1
• 229920000736 dendritic polymer Polymers 0.000 description 1
• 238000010511 deprotection reaction Methods 0.000 description 1
• 235000011850 desserts Nutrition 0.000 description 1
• 125000005265 dialkylamine group Chemical group 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• 125000005266 diarylamine group Chemical group 0.000 description 1
• WLSIFTFRHXOJFE-UHFFFAOYSA-N diazonio-[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]carbamoylamino]ethoxy]ethoxy]ethoxy]ethyl]azanide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NC(=O)NCCOCCOCCOCCN=[N+]=[N-])=C1 WLSIFTFRHXOJFE-UHFFFAOYSA-N 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 229940043279 diisopropylamine Drugs 0.000 description 1
• PNLXWGDXZOYUKB-PGMHMLKASA-N dimethyl (2r)-2-aminobutanedioate;hydrochloride Chemical compound Cl.COC(=O)C[C@@H](N)C(=O)OC PNLXWGDXZOYUKB-PGMHMLKASA-N 0.000 description 1
• BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 1
• PYHXGXCGESYPCW-UHFFFAOYSA-N diphenylacetic acid Chemical compound C=1C=CC=CC=1C(C(=O)O)C1=CC=CC=C1 PYHXGXCGESYPCW-UHFFFAOYSA-N 0.000 description 1
• WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
• KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 238000004821 distillation Methods 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 230000007831 electrophysiology Effects 0.000 description 1
• 238000002001 electrophysiology Methods 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 201000000523 end stage renal failure Diseases 0.000 description 1
• 210000001842 enterocyte Anatomy 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
• PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
• 229940012017 ethylenediamine Drugs 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 210000003722 extracellular fluid Anatomy 0.000 description 1
• 210000001723 extracellular space Anatomy 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 239000004744 fabric Substances 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 229960002011 fludrocortisone Drugs 0.000 description 1
• AAXVEMMRQDVLJB-BULBTXNYSA-N fludrocortisone Chemical group O=C1CC[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 AAXVEMMRQDVLJB-BULBTXNYSA-N 0.000 description 1
• ZYMKZMDQUPCXRP-UHFFFAOYSA-N fluoro prop-2-enoate Chemical group FOC(=O)C=C ZYMKZMDQUPCXRP-UHFFFAOYSA-N 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 235000019253 formic acid Nutrition 0.000 description 1
• 238000001640 fractional crystallisation Methods 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 235000011087 fumaric acid Nutrition 0.000 description 1
• 125000002541 furyl group Chemical group 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 230000014509 gene expression Effects 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 210000004907 gland Anatomy 0.000 description 1
• 239000003862 glucocorticoid Substances 0.000 description 1
• 229950006191 gluconic acid Drugs 0.000 description 1
• 229960002442 glucosamine Drugs 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 description 1
• 239000001685 glycyrrhizic acid Substances 0.000 description 1
• 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
• 229940126514 guanylate cyclase activator Drugs 0.000 description 1
• 239000003119 guanylate cyclase activator Substances 0.000 description 1
• 238000001631 haemodialysis Methods 0.000 description 1
• 150000004820 halides Chemical class 0.000 description 1
• 125000005843 halogen group Chemical group 0.000 description 1
• 210000002064 heart cell Anatomy 0.000 description 1
• 230000000322 hemodialysis Effects 0.000 description 1
• 125000004475 heteroaralkyl group Chemical group 0.000 description 1
• 125000004446 heteroarylalkyl group Chemical group 0.000 description 1
• 210000001320 hippocampus Anatomy 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 229960002885 histidine Drugs 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 description 1
• 150000002430 hydrocarbons Chemical group 0.000 description 1
• 238000005984 hydrogenation reaction Methods 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 230000003301 hydrolyzing effect Effects 0.000 description 1
• GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
• HQZMRJBVCVYVQA-UHFFFAOYSA-N hydron;methyl 2-(methylamino)acetate;chloride Chemical compound Cl.CNCC(=O)OC HQZMRJBVCVYVQA-UHFFFAOYSA-N 0.000 description 1
• COQRGFWWJBEXRC-UHFFFAOYSA-N hydron;methyl 2-aminoacetate;chloride Chemical compound Cl.COC(=O)CN COQRGFWWJBEXRC-UHFFFAOYSA-N 0.000 description 1
• 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 1
• 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 1
• 150000002466 imines Chemical class 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 230000008676 import Effects 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 125000001041 indolyl group Chemical group 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 150000007529 inorganic bases Chemical class 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
• 238000005342 ion exchange Methods 0.000 description 1
• 239000003456 ion exchange resin Substances 0.000 description 1
• 229920003303 ion-exchange polymer Polymers 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• 125000000842 isoxazolyl group Chemical group 0.000 description 1
• 229940059939 kayexalate Drugs 0.000 description 1
• 229940112584 kionex Drugs 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 150000002596 lactones Chemical class 0.000 description 1
• 229960000511 lactulose Drugs 0.000 description 1
• 125000002099 lactulose group Chemical group 0.000 description 1
• PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
• 239000010410 layer Substances 0.000 description 1
• 229910052745 lead Inorganic materials 0.000 description 1
• 229940010454 licorice Drugs 0.000 description 1
• 229940069445 licorice extract Drugs 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• KXGCNMMJRFDFNR-WDRJZQOASA-N linaclotide Chemical group C([C@H](NC(=O)[C@@H]1CSSC[C@H]2C(=O)N[C@H]3CSSC[C@H](N)C(=O)N[C@H](C(N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N2)=O)CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC3=O)C(=O)N[C@H](C(NCC(=O)N1)=O)[C@H](O)C)C(O)=O)C1=CC=C(O)C=C1 KXGCNMMJRFDFNR-WDRJZQOASA-N 0.000 description 1
• 108010024409 linaclotide Proteins 0.000 description 1
• 229960000812 linaclotide Drugs 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 239000012280 lithium aluminium hydride Substances 0.000 description 1
• 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 238000003819 low-pressure liquid chromatography Methods 0.000 description 1
• WGFOBBZOWHGYQH-MXHNKVEKSA-N lubiprostone Chemical group O1[C@](C(F)(F)CCCC)(O)CC[C@@H]2[C@@H](CCCCCCC(O)=O)C(=O)C[C@H]21 WGFOBBZOWHGYQH-MXHNKVEKSA-N 0.000 description 1
• 229960000345 lubiprostone Drugs 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 229960003646 lysine Drugs 0.000 description 1
• 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• UNYOJUYSNFGNDV-UHFFFAOYSA-M magnesium monohydroxide Chemical group [Mg]O UNYOJUYSNFGNDV-UHFFFAOYSA-M 0.000 description 1
• 159000000003 magnesium salts Chemical class 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 239000011976 maleic acid Substances 0.000 description 1
• 239000001630 malic acid Substances 0.000 description 1
• 235000011090 malic acid Nutrition 0.000 description 1
• 229960002510 mandelic acid Drugs 0.000 description 1
• WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 229910052987 metal hydride Inorganic materials 0.000 description 1
• 150000004681 metal hydrides Chemical class 0.000 description 1
• 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
• 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• GRWIABMEEKERFV-UHFFFAOYSA-N methanol;oxolane Chemical compound OC.C1CCOC1 GRWIABMEEKERFV-UHFFFAOYSA-N 0.000 description 1
• 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
• NDBQJIBNNUJNHA-DFWYDOINSA-N methyl (2s)-2-amino-3-hydroxypropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CO NDBQJIBNNUJNHA-DFWYDOINSA-N 0.000 description 1
• IYUKFAFDFHZKPI-DFWYDOINSA-N methyl (2s)-2-aminopropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@H](C)N IYUKFAFDFHZKPI-DFWYDOINSA-N 0.000 description 1
• XWPWFILACZRQRM-UHFFFAOYSA-N methyl 2-(2-methoxy-2-oxoethyl)sulfonylacetate Chemical compound COC(=O)CS(=O)(=O)CC(=O)OC XWPWFILACZRQRM-UHFFFAOYSA-N 0.000 description 1
• RXYCUKSOYJWGPE-UHFFFAOYSA-N methyl 2-azidoacetate Chemical compound COC(=O)CN=[N+]=[N-] RXYCUKSOYJWGPE-UHFFFAOYSA-N 0.000 description 1
• ZXUQEPZWVQIOJE-UHFFFAOYSA-N methyl 2-chloro-2-oxoacetate Chemical compound COC(=O)C(Cl)=O ZXUQEPZWVQIOJE-UHFFFAOYSA-N 0.000 description 1
• QABLOFMHHSOFRJ-UHFFFAOYSA-N methyl 2-chloroacetate Chemical compound COC(=O)CCl QABLOFMHHSOFRJ-UHFFFAOYSA-N 0.000 description 1
• YBIPZPBGAGTBGK-UHFFFAOYSA-N methyl 2-chlorosulfonylacetate Chemical compound COC(=O)CS(Cl)(=O)=O YBIPZPBGAGTBGK-UHFFFAOYSA-N 0.000 description 1
• UTBCRHAMJFMIIR-UHFFFAOYSA-N methyl 3-chloro-3-oxopropanoate Chemical compound COC(=O)CC(Cl)=O UTBCRHAMJFMIIR-UHFFFAOYSA-N 0.000 description 1
• LWJZGJNMJBUUMC-UHFFFAOYSA-N methyl 3-chlorosulfonylpropanoate Chemical compound COC(=O)CCS(Cl)(=O)=O LWJZGJNMJBUUMC-UHFFFAOYSA-N 0.000 description 1
• IVECIWLVOYDMRU-UHFFFAOYSA-N methyl acetate Chemical compound COC(C)=O.COC(C)=O IVECIWLVOYDMRU-UHFFFAOYSA-N 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
• GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
• 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
• 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 229940060946 miralax Drugs 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 230000009149 molecular binding Effects 0.000 description 1
• NKHAVTQWNUWKEO-NSCUHMNNSA-N monomethyl fumarate Chemical compound COC(=O)\C=C\C(O)=O NKHAVTQWNUWKEO-NSCUHMNNSA-N 0.000 description 1
• JDRMYOQETPMYQX-UHFFFAOYSA-N monomethyl succinate Chemical compound COC(=O)CCC(O)=O JDRMYOQETPMYQX-UHFFFAOYSA-N 0.000 description 1
• 235000019799 monosodium phosphate Nutrition 0.000 description 1
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
• 125000002757 morpholinyl group Chemical group 0.000 description 1
• LAHZBPLSUPFJGA-UHFFFAOYSA-N n'-[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]butanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)CCC(N)=O)=C1 LAHZBPLSUPFJGA-UHFFFAOYSA-N 0.000 description 1
• PTMNNUHCKOUXCE-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[2-[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)anilino]ethoxy]ethoxy]ethoxy]ethyl]-2,3-dihydroxybutanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(NCCOCCOCCOCCNC(=O)C(O)C(O)C(=O)NCCOCCOCCOCCNC=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 PTMNNUHCKOUXCE-UHFFFAOYSA-N 0.000 description 1
• FHRLGPHMKILQAM-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[2-[[3-(6,8-dichloro-2-ethyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]-2,3-dihydroxybutanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(CC)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)C(O)C(O)C(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(CC)C2)=C1 FHRLGPHMKILQAM-UHFFFAOYSA-N 0.000 description 1
• XHHVVYGRPMXSBQ-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]-2,2-dimethylpropanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)C(C)(C)C(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 XHHVVYGRPMXSBQ-UHFFFAOYSA-N 0.000 description 1
• MYECOULROLTFLA-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]butanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)CCC(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 MYECOULROLTFLA-UHFFFAOYSA-N 0.000 description 1
• JKWUQUWBSOFKNX-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]octanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)CCCCCCC(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 JKWUQUWBSOFKNX-UHFFFAOYSA-N 0.000 description 1
• QLPSAMKHYRLWJA-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]butanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCOCCOCCOCCNC(=O)CCC(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 QLPSAMKHYRLWJA-UHFFFAOYSA-N 0.000 description 1
• BFOGCZFQXSLNRQ-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-2,2-dimethylpropanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCNC(=O)C(C)(C)C(=O)NCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 BFOGCZFQXSLNRQ-UHFFFAOYSA-N 0.000 description 1
• HOEUFIGPLAGCMD-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]butanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCNC(=O)CCC(=O)NCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 HOEUFIGPLAGCMD-UHFFFAOYSA-N 0.000 description 1
• SSTIHKGIHJYMCG-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-2,2-dimethylpropanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCOCCOCCNC(=O)C(C)(C)C(=O)NCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 SSTIHKGIHJYMCG-UHFFFAOYSA-N 0.000 description 1
• ALMVJCXGEFLRBW-UHFFFAOYSA-N n,n'-bis[2-[2-[2-[[4-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-2,3-dihydroxybutanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=C(S(=O)(=O)NCCOCCOCCNC(=O)C(O)C(O)C(=O)NCCOCCOCCNS(=O)(=O)C=2C=CC(=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)C=C1 ALMVJCXGEFLRBW-UHFFFAOYSA-N 0.000 description 1
• GQYVSHAUWGIIFU-UHFFFAOYSA-N n,n'-bis[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethyl]-2,3-dihydroxybutanediamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCNC(=O)C(O)C(O)C(=O)NCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 GQYVSHAUWGIIFU-UHFFFAOYSA-N 0.000 description 1
• OPWVGEUBXJEABG-UHFFFAOYSA-N n-[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethyl]-2-[2-[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethoxy]ethylamino]-2-o Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCOCCNC(=O)COCC(=O)NCCOCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 OPWVGEUBXJEABG-UHFFFAOYSA-N 0.000 description 1
• UQWBSVPMYCBVAF-UHFFFAOYSA-N n-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-2-[2-[2-[2-[2-[[3-(6,8-dichloro-2-methyl-3,4-dihydro-1h-isoquinolin-4-yl)phenyl]sulfonylamino]ethoxy]ethoxy]ethylamino]-2-oxoethoxy]acetamide Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)CC1C1=CC=CC(S(=O)(=O)NCCOCCOCCNC(=O)COCC(=O)NCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)C2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 UQWBSVPMYCBVAF-UHFFFAOYSA-N 0.000 description 1
• 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000001624 naphthyl group Chemical group 0.000 description 1
• 230000008693 nausea Effects 0.000 description 1
• 210000003739 neck Anatomy 0.000 description 1
• 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 210000000885 nephron Anatomy 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• 125000006501 nitrophenyl group Chemical group 0.000 description 1
• 125000006574 non-aromatic ring group Chemical group 0.000 description 1
• 230000000269 nucleophilic effect Effects 0.000 description 1
• 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
• 239000006186 oral dosage form Substances 0.000 description 1
• 150000007530 organic bases Chemical class 0.000 description 1
• 125000001715 oxadiazolyl group Chemical group 0.000 description 1
• 235000006408 oxalic acid Nutrition 0.000 description 1
• 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 description 1
• 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
• 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
• 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
• 210000003254 palate Anatomy 0.000 description 1
• WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 239000002304 perfume Substances 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 229940127557 pharmaceutical product Drugs 0.000 description 1
• 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
• 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
• UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
• 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
• 230000000704 physical effect Effects 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 125000004193 piperazinyl group Chemical group 0.000 description 1
• 229940037129 plain mineralocorticoids for systemic use Drugs 0.000 description 1
• 239000004584 polyacrylic acid Substances 0.000 description 1
• 229920000768 polyamine Polymers 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 229920002744 polyvinyl acetate phthalate Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• JWPGVOJUUSVNTL-UHFFFAOYSA-M potassium;oxido formate Chemical compound [K+].[O-]OC=O JWPGVOJUUSVNTL-UHFFFAOYSA-M 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
• 229960004919 procaine Drugs 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1
• 235000019260 propionic acid Nutrition 0.000 description 1
• 235000018102 proteins Nutrition 0.000 description 1
• 108090000623 proteins and genes Proteins 0.000 description 1
• 102000004169 proteins and genes Human genes 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
• 125000003226 pyrazolyl group Chemical group 0.000 description 1
• 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 1
• PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
• 229940107700 pyruvic acid Drugs 0.000 description 1
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 238000001953 recrystallisation Methods 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 238000010992 reflux Methods 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000035440 response to pH Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 230000033764 rhythmic process Effects 0.000 description 1
• 229960002052 salbutamol Drugs 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 229940043230 sarcosine Drugs 0.000 description 1
• 229930195734 saturated hydrocarbon Natural products 0.000 description 1
• 230000035807 sensation Effects 0.000 description 1
• 239000004208 shellac Substances 0.000 description 1
• ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
• 229940113147 shellac Drugs 0.000 description 1
• 235000013874 shellac Nutrition 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 239000002356 single layer Substances 0.000 description 1
• 229960001407 sodium bicarbonate Drugs 0.000 description 1
• UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
• AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 229940006186 sodium polystyrene sulfonate Drugs 0.000 description 1
• AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
• 235000019345 sodium thiosulphate Nutrition 0.000 description 1
• 239000008247 solid mixture Substances 0.000 description 1
• 239000011877 solvent mixture Substances 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 238000000859 sublimation Methods 0.000 description 1
• 230000008022 sublimation Effects 0.000 description 1
• 125000004354 sulfur functional group Chemical group 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 229920002994 synthetic fiber Polymers 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 229940037128 systemic glucocorticoids Drugs 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• DNHPDWGIXIMXSA-CXNSMIOJSA-N tenapanor Chemical compound C12=CC(Cl)=CC(Cl)=C2CN(C)C[C@H]1C1=CC=CC(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C=2C=C(C=CC=2)[C@H]2C3=CC(Cl)=CC(Cl)=C3CN(C)C2)=C1 DNHPDWGIXIMXSA-CXNSMIOJSA-N 0.000 description 1
• OSWULUXZFOQIRU-UHFFFAOYSA-N tert-butyl 2-aminoacetate;hydrochloride Chemical compound Cl.CC(C)(C)OC(=O)CN OSWULUXZFOQIRU-UHFFFAOYSA-N 0.000 description 1
• KUYMVWXKHQSIAS-UHFFFAOYSA-N tert-butyl 2-chloroacetate Chemical compound CC(C)(C)OC(=O)CCl KUYMVWXKHQSIAS-UHFFFAOYSA-N 0.000 description 1
• XRGDJVAGXXEXMK-UHFFFAOYSA-N tert-butyl 2-ethoxypropanoate Chemical compound CCOC(C)C(=O)OC(C)(C)C XRGDJVAGXXEXMK-UHFFFAOYSA-N 0.000 description 1
• ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
• 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
• 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
• 125000005247 tetrazinyl group Chemical group N1=NN=NC(=C1)* 0.000 description 1
• 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 description 1
• 125000003831 tetrazolyl group Chemical group 0.000 description 1
• 229960004559 theobromine Drugs 0.000 description 1
• 125000004525 thiadiazinyl group Chemical group S1NN=C(C=C1)* 0.000 description 1
• 125000001113 thiadiazolyl group Chemical group 0.000 description 1
• 125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 description 1
• 125000001544 thienyl group Chemical group 0.000 description 1
• 230000035922 thirst Effects 0.000 description 1
• YONPGGFAJWQGJC-UHFFFAOYSA-K titanium(iii) chloride Chemical compound Cl[Ti](Cl)Cl YONPGGFAJWQGJC-UHFFFAOYSA-K 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 125000005591 trimellitate group Chemical group 0.000 description 1
• 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
• 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
• 210000002700 urine Anatomy 0.000 description 1
• 229940097274 veltassa Drugs 0.000 description 1
• 230000002861 ventricular Effects 0.000 description 1
• 230000008673 vomiting Effects 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1